Annual Statements Open main menu

TERADYNE, INC - Quarter Report: 2022 April (Form 10-Q)

Table of Contents
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 10-Q
 
 

(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 3, 2022
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to
                    
Commission File
No. 001-06462
 
 
TERADYNE, INC.
(Exact name of registrant as specified in its charter)
 
 
 
Massachusetts
 
04-2272148
(State or Other Jurisdiction of
Incorporation or Organization)
 
(I.R.S. Employer
Identification No.)
   
600 Riverpark Drive, North Reading,
Massachusetts
 
01864
(Address of Principal Executive Offices)
 
(Zip Code)
978-370-2700
(Registrant’s Telephone Number, Including Area Code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, par value $0.125
 per share
 
TER
 
Nasdaq Stock Market LLC
Indicate
by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in
Rule 12b-2
of the Exchange Act (check one):
 
Large accelerated filer      Accelerated filer  
       
Non-accelerated
filer
     Emerging growth company  
       
Smaller reporting company           
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☐    No  ☒
The number of shares outstanding of the registrant’s only class of Common Stock as of May 2, 2022 was
 160,203,017 shares.
 
 
 

Table of Contents
TERADYNE, INC.
INDEX
 
 
  
 
  
Page No.
 
  
PART I. FINANCIAL INFORMATION
  
Item 1.
  
Financial Statements (Unaudited):
  
  
  
 
1
 
  
  
 
2
 
  
  
 
3
 
  
  
 
4
 
  
  
 
5
 
  
  
 
6
 
Item 2.
  
  
 
26
 
Item 3.
  
  
 
33
 
Item 4.
  
  
 
34
 
  
PART II. OTHER INFORMATION
  
Item 1.
  
  
 
34
 
Item 1A.
  
  
 
35
 
Item 2.
  
  
 
35
 
Item 4.
  
  
 
35
 
Item 6.
  
  
 
36
 

Table of Contents
PART I
 
Item 1:
Financial Statements
TERADYNE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
 
 
  
April 3,

2022
 
 
December 31,
2021
 
 
  
 
 
 
 
 
 
  
(in thousands,
except per share amount)
 
ASSETS
  
 
 
 
 
 
Current assets:
  
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
   $ 794,603     $ 1,122,199  
Marketable securities
     282,016       244,231  
Accounts receivable, less allowance for credit losses of $1,891 and $2,012 at April 3, 2022 and December 31, 2021, respectively
     546,881       550,749  
Inventories, net
     259,341       243,330  
Prepayments
     479,414       406,266  
Other current assets
     12,127       9,452  
    
 
 
   
 
 
 
Total current assets
     2,374,382       2,576,227  
Property, plant and equipment, net
     399,485       387,240  
Operating lease
right-of-use
assets, net
     67,718       68,807  
Marketable securities
     126,130       133,858  
Deferred tax assets
     113,556       102,428  
Retirement plans assets
     14,669       15,110  
Other assets
     23,480       24,096  
Acquired intangible assets, net
     69,846       75,635  
Goodwill
     419,888       426,024  
    
 
 
   
 
 
 
Total assets
   $ 3,609,154     $ 3,809,425  
  
 
 
 
 
 
 
 
LIABILITIES
  
 
 
 
 
 
Current liabilities:
  
 
Accounts payable
   $ 156,493     $ 153,133  
Accrued employees’ compensation and withholdings
     139,287       253,667  
Deferred revenue and customer advances
     155,761       146,185  
Other accrued liabilities
     118,252       124,187  
Operating lease liabilities
     18,523       19,977  
Income taxes payable
     103,386       88,789  
Current debt
     20,497       19,182  
    
 
 
   
 
 
 
Total current liabilities
     712,199       805,120  
Retirement plans liabilities
     151,697       151,141  
Long-term deferred revenue and customer advances
     51,698       54,921  
Long-term other accrued liabilities
     15,748       15,497  
Deferred tax liabilities
     4,927       6,327  
Long-term operating lease liabilities
     55,934       56,178  
Long-term incomes taxes payable
     67,041       67,041  
Debt
     75,378       89,244  
    
 
 
   
 
 
 
Total liabilities
     1,134,622       1,245,469  
    
 
 
   
 
 
 
Commitments and contingencies (
N
ote
Q
)
            
Mezzanine equity:
                
Convertible common shares
     —         1,512  
SHAREHOLDERS’ EQUITY
  
 
 
 
 
 
Common stock, $0.125 par value, 1,000,000 shares authorized; 161,053 and 162,251 shares issued and outstanding at April 3, 2022 and December 31, 2021, respectively
     20,132       20,281  
Additional
paid-in
capital
     1,711,690       1,811,545  
Accumulated other comprehensive loss
     (19,479     (5,948
Retained earnings
     762,189       736,566  
    
 
 
   
 
 
 
Total shareholders’ equity
     2,474,532       2,562,444  
    
 
 
   
 
 
 
Total liabilities, convertible common shares and shareholders’ equity
   $ 3,609,154     $ 3,809,425  
    
 
 
   
 
 
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s Annual Report
on Form
10-K
for the year ended December 31, 2021, are an integral part of the condensed consolidated financial statements.
 
1

TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
 
  
For the Three Months

Ended
 
 
  
April 3,
2022
 
 
April 4,
2021
 
 
  
 
 
 
 
 
 
  
(in thousands, except per
share amount)
 
 
 
 
 
 
 
 
 
 
Revenues:
                
Products
   $ 625,875     $ 660,508  
Services
     129,495       121,098  
    
 
 
   
 
 
 
Total revenues
     755,370       781,606  
Cost of revenues:
                
Cost of products
     243,016       267,784  
Cost of services
     57,421       52,204  
    
 
 
   
 
 
 
Total cost of revenues (exclusive of acquired intangible
assets amortization shown separately below)
     300,437       319,988  
    
 
 
   
 
 
 
Gross profit
     454,933       461,618  
Operating expenses:
                
Selling and administrative
     140,185       129,797  
Engineering and development
     108,116       100,402  
Acquired intangible assets amortization
     5,063       5,536  
Restructuring and other
     15,714       (7,130
    
 
 
   
 
 
 
Total operating expenses
     269,078       228,605  
    
 
 
   
 
 
 
Income from operations
     185,855       233,013  
Non-operating
(income) expense:
                
Interest income
     (703     (808
Interest expense
     1,012       6,004  
Other (income) expense, net
     5,187       3,824  
    
 
 
   
 
 
 
Income before income taxes
     180,359       223,993  
Income tax provision
     18,431       18,481  
    
 
 
   
 
 
 
Net income
   $ 161,928     $ 205,512  
    
 
 
   
 
 
 
Net income per common share:
                
Basic
   $ 1.00     $ 1.23  
    
 
 
   
 
 
 
Diluted
   $ 0.92     $ 1.09  
    
 
 
   
 
 
 
Weighted average common shares—basic
     162,048       166,491  
    
 
 
   
 
 
 
Weighted average common shares—diluted
     175,575       187,740  
    
 
 
   
 
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2021, are an integral part of the condensed
consolidated financial statements.
 
2

TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
 
 
  
For the Three Months

Ended
 
 
  
April 3,
2022
 
 
April 4,
2021
 
 
  
 
 
 
 
 
 
  
(in thousands)
 
Net income
   $ 161,928    
$205,512  
Other comprehensive income, net of tax:
                
Foreign currency translation adjustment, net of tax of $0 and $0, respectively
     (8,076     (21,123
Available-for-sale
marketable securities:
                
Unrealized losses on marketable securities arising during period, net of tax of $(1,333) and $(908), respectively
     (5,388     (3,270
Less: Reclassification adjustment for gains included in net income, net of tax of $(18) and $(123), respectively
     (65     (444
    
 
 
   
 
 
 
       (5,453     (3,714
Defined benefit post-retirement plan:
                
Amortization of prior service credit, net of tax of $0 and $0, respectively
     (2     (2
    
 
 
   
 
 
 
Other comprehensive loss
     (13,531     (24,839
    
 
 
   
 
 
 
Comprehensive income
  
$148,397    
$180,673  
    
 
 
   
 
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2021, are an integral part of the condensed
consolidated financial statements.
 
3

TERADYNE, INC.
CONDENSED STATEMENTS OF CONVERTIBLE COMMON SHARES
AND SHAREHOLDERS’ EQUITY
(Unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
Shareholders’ Equity
 
    
Convertible
Common
Shares
Value
   
Common
Stock Shares
   
Common
Stock Par
Value
   
Additional
Paid-in Capital
   
Accumulated
Other
Comprehensive
(Loss) Income
   
Retained
Earnings
   
Total
Shareholders’
Equity
 
          
(in thousands)
 
For the Three Months Ended April 3, 2022
                                                        
Balance, December 31, 2021
   $ 1,512       162,251     $ 20,281     $ 1,811,545     $ (5,948   $ 736,566     $ 2,562,444  
Net issuance of common stock under stock-based plans
             552       70       (14,644                     (14,574
Stock-based compensation expense
                             14,204                       14,204  
Repurchase of common stock
             (1,750     (219                     (211,247     (211,466
Cash dividends ($0.11 per share)
                                             (17,908     (17,908
Settlements of convertible notes
             509       64       (157 )                     (93 )
Exercise of convertible notes hedge call options
             (509     (64     64                        
Cumulative-effect of change in accounting principle related to convertible debt
     (1,512                     (99,322             92,850       (6,472
Net income
                                             161,928       161,928  
Other comprehensive loss
                                     (13,531             (13,531
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance, April 3, 2022
   $ —         161,053     $ 20,132     $ 1,711,690     $ (19,479   $ 762,189     $ 2,474,532  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
For the Three Months Ended April 4, 2021
                                                        
Balance, December 31, 2020
   $ 3,787       166,123     $ 20,765     $ 1,765,323     $ 33,516     $ 387,414     $ 2,207,018  
Net issuance of common stock under stock-based plans
             670       84       (14,071                     (13,987
Stock-based compensation expense
                             13,359                       13,359  
Repurchase of common stock
             (374     (47                     (47,141     (47,188
Cash dividends ($0.10 per share)
                                             (16,682     (16,682
Settlements of convertible notes
             1,222       153       157,529                       157,682  
Exercise of convertible notes hedge call options
             (1,222     (153     (158,723                     (158,876
Convertible common shares
     (2,554                     2,554                       2,554  
Net income
                                             205,512       205,512  
Other comprehensive loss
                                     (24,839             (24,839
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance, April 4, 2021
   $ 1,233       166,419     $ 20,802     $ 1,765,971     $ 8,677     $ 529,103     $ 2,324,553  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2021, are an integral part of the condensed
consolidated financial statements.
 
4

TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
 
  
For the Three Months
Ended
 
 
  
April 3,

2022
 
 
April 4,

2021
 
 
  
 
 
 
 
 
 
  
(in thousands)
 
Cash flows from operating activities:
  
 
 
 
 
 
 
 
 
 
 
Net income
   $ 161,928     $ 205,512  
Adjustments to reconcile net income from operations to net cash provided by operating activities:
                
Depreciation
     22,503       23,910  
Stock-based compensation
     12,894       12,232  
Amortization
     5,233       9,822  
Deferred taxes
     11,288       (1,057
Losses (gains) on investments
     2,001       (2,491
Provision for excess and obsolete inventory
     1,590       2,285  
Loss on convertible debt conversion
s
     —         4,069  
Contingent consideration fair value adjustment
s
     —         (7,227
Other
     177       200  
Changes in operating assets and liabilities
                
Accounts receivable
     208       (87,512
Inventories
     (9,480     (35,870
Prepayments and other assets
     (74,305     (86,131
Accounts payable and other accrued expenses
     (124,382     (10,571
Deferred revenue and customer advances
     6,747       7,952  
Retirement plan contributions
     (1,329     (1,925
Income taxes
     (7,611     4,941  
    
 
 
   
 
 
 
Net cash provided by operating activities
     7,462       38,139  
    
 
 
   
 
 
 
Cash flows from investing activities:
                
Purchases of property, plant and equipment
     (43,999     (39,250
Purchases of marketable securities
     (165,977     (211,604
Proceeds from maturities of marketable securities
     96,682       194,228  
Proceeds from sales of marketable securities
     30,581       61,293  
    
 
 
   
 
 
 
Net cash (used for) provided by investing activities
     (82,713     4,667  
    
 
 
   
 
 
 
Cash flows from financing activities:
                
Issuance of common stock under stock purchase and stock option plans
     16,475       17,144  
Repurchase of common stock
     (201,465     (45,188
Payments related to net settlement of employee stock compensation awards
     (31,048     (30,675
Payments of convertible debt principal
     (20,694     (51,275
Dividend payments
     (17,895     (16,667
    
 
 
   
 
 
 
Net cash used for financing activities
     (254,627     (126,661
    
 
 
   
 
 
 
Effects of exchange rate changes on cash and cash equivalents
     2,282       883  
    
 
 
   
 
 
 
Decrease in cash and cash equivalents
     (327,596     (82,972
Cash and cash equivalents at beginning of period
     1,122,199       914,121  
    
 
 
   
 
 
 
Cash and cash equivalents at end of period
   $ 794,603     $ 831,149  
    
 
 
   
 
 
 
Non-cash
investing activities:
                
Capital expenditures incurred but not yet paid:
   $ 2,500     $ 3,840  
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2021, are an integral part of the condensed
consolidated financial statements.
 
5

TERADYNE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
A. THE COMPANY
Teradyne, Inc. (“Teradyne”) is a leading global supplier of automation equipment for test and industrial applications. Teradyne designs, develops, manufactures and sells automatic test systems used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Teradyne’s industrial automation products include collaborative robotic arms, autonomous mobile robots, and advanced robotic control software used by global manufacturing, logistics and light industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Teradyne’s automatic test equipment and industrial automation products and services include:
 
   
semiconductor test (“Semiconductor Test”) systems;
 
   
storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”);
 
   
wireless test (“Wireless Test”) systems; and
 
   
industrial automation (“Industrial Automation”) products.
B. ACCOUNTING POLICIES
Basis of Presentation
The consolidated interim financial statements include the accounts of Teradyne and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. Certain prior year amounts may have been reclassified to conform to the current year presentation. The December 31, 2021 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by United States of America generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in Teradyne’s Annual Report on Form
10-K,
filed with the U.S. Securities and Exchange Commission (“SEC”) on February 23, 2022, for the year ended December 31, 2021.
Preparation of Financial Statements and Use of Estimates
The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent liabilities. On an
on-going
basis, management evaluates its estimates, including those related to inventories, investments, goodwill, intangible and other long-lived assets, accounts receivable, income taxes, deferred tax assets and liabilities, pensions, warranties, and loss contingencies. Management bases its estimates on historical experience and on appropriate and customary assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgements about the carrying values of assets and liabilities that are not readily apparent from other sources. Due to the
COVID-19
pandemic, there has been uncertainty and disruption in the global economy and our markets. Management is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of this Quarterly Report on Form
10-Q.
These estimates may change, as new events occur and additional information is obtained. Actual results may differ significantly from these estimates under different assumptions or conditions.
Convertible Debt
Teradyne adopted Accounting Standards Update (“ASU”) ASU
2020-06
“Debt—Debt with Conversion and Other Options and Derivatives and Hedging—Contracts in Entity’s Own Equity,”
on January 1, 2022 using the modified retrospective method of adoption
.
Under ASU
2020-06,
Teradyne accounts for a convertible debt instrument as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Unsettled shares are recorded in current debt, and there is no recognition of a debt discount, which was previously amortized to interest expense. Teradyne uses the
if-converted
method in the diluted earnings per share (“EPS”) calculation for convertible instruments. As a result of adoption, Teradyne recorded an increase
of
$1.4 million to current debt for unsettled shares, an increase of $6.6 million to long-term
debt
for unamortized debt discount, and an increase to retained earnings of $92.8 million for the reclassification of the equity component. Mezzanine equity representing unsettled shares value was reduced to zero and additional
paid-in
capital was reduced by $99.3 million.
 
6

C. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
For the three months ended April 3, 2022, there were no recently issued accounting pronouncements that had, or are expected to have, a material impact to Teradyne’s consolidated financial statements.
 
D. INVESTMENT IN OTHER COMPANY
On June 1, 2021, Teradyne invested $12.0 million in MachineMetrics, Inc. (“MachineMetrics”), a private company that develops and sells products to improve manufacturing performance through automated machine data collection, alerting, and analytics. Teradyne’s investment in MachineMetrics aligns with its strategy of providing and investing in leading edge products for automating industrial production processes in growing markets. The investment was recorded at cost and is evaluated for impairment or an indication of changes in fair value resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer on a quarterly basis. At April 3, 2022, the value of the investment was $12.0 million, and there was no change during the three months ended April 3, 2022.
E. REVENUE
Disaggregation of Revenue
The following table provides information about disaggregated revenue by timing of revenue recognition, primary geographical market, and major product lines.
 
 
  
Semiconductor Test
 
  
 
 
  
Industrial Automation
 
 
 
 
  
 
 
 
 
 
 
  
System
on-a-

Chip
 
  
Memory
 
  
System

Test
 
  
Universal
Robots
 
  
Mobile
Industrial
Robots
 
  
AutoGuide
 
 
Wireless

Test
 
  
Corporate

and

Eliminations
 
 
Total
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
  
(in thousands)
 
For the Three Months Ended April 3, 2022 (1)
  
  
  
  
  
  
 
  
 
Timing of Revenue Recognition
  
  
  
  
  
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Point in Time
  $ 323,456     $ 88,723     $ 105,288     $ 83,182     $ 16,534     $ 210     $ 48,429     $ (346   $ 665,476  
Over Time
    63,129       7,033       13,380       2,102       674       487       3,089       —          89,894  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $ 386,585     $ 95,756     $ 118,668     $ 85,284     $ 17,208     $ 697     $ 51,518     $ (346   $ 755,370  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Geographical Market
                                                                       
Asia Pacific
  $ 340,741     $ 93,151     $ 73,784     $ 18,621     $ 2,592     $ —       $ 34,946     $ —       $ 563,835  
Americas
    29,714       2,046       36,608       28,148       7,867       697       9,687       (346     114,421  
Europe, Middle East and
Africa
    16,130       559       8,276       38,515       6,749       —         6,885       —         77,114  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $ 386,585     $ 95,756     $ 118,668     $ 85,284     $ 17,208     $ 697     $ 51,518     $ (346   $ 755,370  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
For the Three Months Ended April 4, 2021 (1)
                                                                       
Timing of Revenue Recognition
                                                                       
Point in Time
  $ 364,190     $ 101,892     $ 119,314     $ 64,007     $ 14,064     $ (120   $ 37,880     $ (143   $ 701,084  
Over Time
    56,040       5,941       13,523       1,594       67       339       3,018       —         80,522  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $ 420,230     $ 107,833     $ 132,837     $ 65,601     $ 14,131     $ 219     $ 40,898     $ (143   $ 781,606  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Geographical Market
                                                                       
Asia Pacific
  $ 387,236     $ 104,049     $ 99,520     $ 17,833     $ 3,447     $ —       $ 33,532     $ —       $ 645,617  
Americas
    20,779       3,420       27,659       18,153       5,153       219       5,769       (143     81,009  
Europe, Middle East and
Africa
    12,215       364       5,658       29,615       5,531       —         1,597       —         54,980  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $ 420,230     $ 107,833     $ 132,837     $ 65,601     $ 14,131     $ 219     $ 40,898     $ (143   $ 781,606  
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes $2.3 million and $3.1 million in 2022 and 2021, respectively, for leases of Teradyne’s systems recognized outside Accounting Standards Codification (“ASC”) 606
“Revenue from Contracts with Customers.”
 
7

Contract Balances
During the three months ended April 3, 2022 and April 4, 2021, Teradyne recognized $35.0 million and $27.8 million, respectively, that was previously included within the deferred revenue and customer advances balances at the beginning of the period. This revenue primarily relates to undelivered hardware, extended warranties, training, application support, and post contract support. Each of these represents a distinct performance obligation. As of April 3, 2022, Teradyne has $1,417.4 million of unsatisfied performance obligations. Teradyne expects to recognize 89% of the remaining performance obligations in the next 12 months
 
and
11% in
1-3
years.
Deferred revenue and customer advances consist of the following and are included in short and long-term deferred revenue and customer advances on the balance sheet:
 
 
  
April 3,

2022
 
  
December 31,
2021
 
 
  
(in thousands)
 
Maintenance, service and training
  
$
83,212
 
  
$
81,826
 
Customer advances, undelivered elements and other
  
 
58,521
 
  
 
55,112
 
Extended warranty
  
 
65,726
 
  
 
64,168
 
 
  
 
 
 
  
 
 
 
Total deferred revenue and customer advances
  
$
207,459
 
  
$
201,106
 
 
  
 
 
 
  
 
 
 
Accounts Receivable
During the three months ended April 3, 2022 and April 4, 2021, Teradyne sold certain trade accounts receivables on a non-recourse basis to third-party financial institutions pursuant to factoring agreements. During the three months ended April 3, 2022 and April 4, 2021, total trade accounts receivable sold under the factoring agreements were
$19.4 million and $7.3 million
,
respectively. Factoring fees for the sales of receivables were recorded in interest expense and were not material. Teradyne accounted for these transactions as sales of receivables and presented cash proceeds as cash provided
by
operating activities in the consolidated statements of cash flows. 
F. INVENTORIES
Inventories, net consisted of the following at April 3, 2022 and December 31, 2021:
 
 
  
April 3,
2022
 
  
December 31,
2021
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
 
 
 
 
 
 
 
 
 
Raw material
   $ 187,856      $ 155,641  
Work-in-process
     30,877        37,740  
Finished goods
     40,608        49,949  
    
 
 
    
 
 
 
     $ 259,341      $ 243,330  
    
 
 
    
 
 
 
Inventory reserves at April 3, 2022 and December 31, 2021 were $112.8 million and $114.1 million, respectively.
G. FINANCIAL INSTRUMENTS
Cash Equivalents
Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.
Marketable Securities
Teradyne’s
available-for-sale
debt securities are classified as Level 2 and equity and debt mutual funds are classified as Level 1. Contingent consideration is classified as Level 3. The vast majority of Level 2 securities are fixed income securities priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.
During the three months ended April 3, 2022 and April 4, 2021, there were no transfers in or out of Level 1, Level 2, or Level 3 financial instruments.
 
8

Realized gains recorded in the three months ended April 3, 2022 and April 4, 2021 were $0.4 million and $1.2 million, respectively. Realized losses recorded in the three months ended April 3, 2022 were $0.2 million. No realized losses were recorded in the three months ended April 4, 2021. Realized gains and losses are included in other (income) expense, net.
Unrealized losses on equity securities recorded in the three months ended April 3, 2022 were $2.2 million. Unrealized gains on equity securities recorded in the three months ended April 4, 2021 were $1.4 million. Unrealized gains and losses on equity securities are included in other (income) expense, net.
Unrealized gains and losses on
available-for-sale
debt securities are included in accumulated other comprehensive income (loss).
The cost of securities sold is based on average cost.
The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of April 3, 2022 and December 31, 2021.
 
 
  
April 3, 2022
 
 
  
Quoted Prices

in Active

Markets for

Identical

Instruments

(Level 1)
 
  
Significant

Other

Observable

Inputs

(Level 2)
 
  
Significant

Unobservable

Inputs

(Level 3)
 
  
Total
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Assets
  
     
  
     
  
     
  
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash
   $ 508,245      $ —        $ —        $ 508,245  
Cash equivalents
     212,647        73,711        —          286,358  
Available-for-sale
securities:
                                   
Commercial paper
     —          179,481        —          179,481  
U.S. Treasury securities
     —          119,837        —          119,837  
Corporate debt securities
     —          53,161        —          53,161  
Debt mutual funds
     7,030        —          —          7,030  
U.S. government agency securities
     —          4,714        —          4,714  
Certificates of deposit and time deposits
     —          1,312        —          1,312  
Non-U.S.
government securities
     —          578        —          578  
Equity securities:
                                   
Mutual funds
     42,033        —          —          42,033  
    
 
 
    
 
 
    
 
 
    
 
 
 
     $ 769,955      $ 432,794      $ —        $ 1,202,749  
Derivative assets
     —          9        —          9  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 769,955      $ 432,803      $ —        $ 1,202,758  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Derivative liabilities
   $ —        $ 469      $ —        $ 469  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ 469      $ —        $ 469  
    
 
 
    
 
 
    
 
 
    
 
 
 
Reported as follows:
  
     
  
     
  
     
  
     
         
 
  
(Level 1)
 
  
(Level 2)
 
  
(Level 3)
 
  
Total
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Assets
  
     
  
     
  
     
  
     
Cash and cash equivalents
   $ 720,892      $ 73,711      $ —        $ 794,603  
Marketable securities
     —          282,016        —          282,016  
Long-term marketable securities
     49,063        77,067        —          126,130  
Prepayments
     —          9        —          9  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 769,955      $ 432,803      $ —        $ 1,202,758  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Other current liabilities
   $ —        $ 469      $ —        $ 469  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ 469      $ —        $ 469  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
9

 
  
December 31, 2021
 
 
  
Quoted Prices

in Active

Markets for

Identical

Instruments

(Level 1)
 
  
Significant

Other

Observable

Inputs

(Level 2)
 
  
Significant

Unobservable

Inputs

(Level 3)
 
  
Total
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Assets
  
     
  
     
  
     
  
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash
   $ 628,740      $ —        $ —        $ 628,740  
Cash equivalents
     412,212        81,247        —          493,459  
Available for sale securities:
                                   
Commercial paper
     —          189,620        —          189,620  
U.S. Treasury securities
     —          77,789        —          77,789  
Corporate debt securities
     —          56,901        —          56,901  
Debt mutual funds
     7,971        —          —          7,971  
U.S. government agency securities
     —          4,610        —          4,610  
Certificates of deposit and time deposits
     —          1,356        —          1,356  
Non-U.S.
government securities
     —          589        —          589  
Equity securities:
                                   
Mutual funds
     39,253        —          —          39,253  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 1,088,176      $ 412,112      $ —        $ 1,500,288  
Derivative assets
     —          92        —          92  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 1,088,176      $ 412,204      $ —        $ 1,500,380  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Derivative liabilities
   $ —        $ 118      $ —        $ 118  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ 118      $ —        $ 118  
    
 
 
    
 
 
    
 
 
    
 
 
 
Reported as follows:
  
     
  
     
  
     
  
     
 
  
(Level 1)
 
  
(Level 2)
 
  
(Level 3)
 
  
Total
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Assets
  
     
  
     
  
     
  
     
Cash and cash equivalents
   $ 1,040,952      $ 81,247      $ —        $ 1,122,199  
Marketable securities
     —          244,231        —          244,231  
Long-term marketable securities
     47,224        86,634        —          133,858  
Prepayments
     —          92        —          92  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 1,088,176      $ 412,204      $ —        $ 1,500,380  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities
                                   
Other current liabilities
   $ —        $ 118      $ —        $ 118  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ 118      $ —        $ 118  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
10

Changes in the fair value of Level 3 contingent consideration for the three months ended April 3, 2022, and April 4, 2021 were as follows:
 
 
  
For the Three Months

Ended
 
 
  
April 3,
2022
 
  
April 4,
2021
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Balance at beginning of period
   $ —        $ 7,227  
Fair value adjustment (a)
     —          (7,227
    
 
 
    
 
 
 
Balance at end of period
   $ —        $ —    
    
 
 
    
 
 
 
 
(a)
In the three months ended April 4, 2021, the fair value of contingent consideration for the earn-outs in connection with the acquisition of AutoGuide was reduced to zero, which resulted in a benefit of $7.2 million, primarily due to a decrease in forecasted revenues and earnings before interest and taxes. 
On March 25, 2022, the arbitration claim filed by Industrial Automation LLC, sellers of AutoGuide, against Teradyne alleging
non-compliance
with the
earn-out
provisions of the Membership Interests Purchase Agreement (the “Purchase Agreement”), dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide was settled
for
$26.7 million. As a result, Teradyne has no remaining
earn-out
obligations.
The carrying amounts and fair values of Teradyne’s financial instruments at April 3, 2022 and December 31, 2021 were as follows:
 
 
  
April 3, 2022
 
  
December 31, 2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
Carrying Value
 
  
Fair Value
 
  
Carrying Value
 
  
Fair Value
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Assets
  
  
  
  
Cash and cash equivalents
   $ 794,603      $ 794,603      $ 1,122,199      $ 1,122,199  
Marketable securities
     408,146        408,146        378,089        378,089  
Derivative assets
     9        9        92        92  
Liabilities
                                   
Derivative liabilities
     469        469        118        118  
Convertible debt
     95,875        323,670        108,426        604,648  
The fair values of accounts receivable, net and accounts payable approximate the carrying value due to the short-term nature of these instruments.
The following table summarizes the composition of
available-for-sale
marketable securities at April 3, 2022:
 
 
  
April 3, 2022
 
 
  
Available-for-Sale
 
  
 
 
 
  
Cost
 
  
Unrealized

Gain
 
  
Unrealized

(Loss)
 
 
Fair Market

Value
 
  
Fair Market

Value of

Investments

with Unrealized

Losses
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
  
(in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial paper
   $ 179,736      $ 3      $ (258   $ 179,481      $ 106,951  
U.S. Treasury securities
     121,504        8        (1,675     119,837        114,043  
Corporate debt securities
     53,079        1,585        (1,503     53,161        32,283  
Debt mutual funds
     7,150        —          (120     7,030        —    
U.S. government agency securities
     4,795        —          (81     4,714        4,714  
Certificates of deposit and time deposits
     1,312        —          —         1,312        —    
Non-U.S.
government securities
     578        —          —         578        —    
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 368,154      $ 1,596      $ (3,637   $ 366,113      $ 257,991  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
 
11

Reported as follows:
 
 
  
Cost
 
  
Unrealized

Gain
 
  
Unrealized

(Loss)
 
 
Fair Market

Value
 
  
Fair Market

Value of

Investments

with Unrealized

Losses
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
  
(in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Marketable securities
   $ 282,563      $ 11      $ (558   $ 282,016      $ 202,243  
Long-term marketable securities
     85,591        1,585        (3,079     84,097        55,748  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 368,154      $ 1,596      $ (3,637   $ 366,113      $ 257,991  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
The following table summarizes the composition of
available-for-sale
marketable securities at December 31, 2021:
 
 
  
December 31, 2021
 
 
  
Available-for-Sale
 
  
 
 
 
  
Cost
 
  
Unrealized

Gain
 
  
Unrealized

(Loss)
 
 
Fair Market

Value
 
  
Fair Market

Value of

Investments

with Unrealized

Losses
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
  
(in thousands)
 
Commercial paper
   $ 189,614      $ 15      $ (9   $ 189,620      $ 22,784  
U.S. Treasury securities
     77,707        551        (470     77,789        46,435  
Corporate debt securities
     52,266        4,863        (227     56,901        19,422  
Debt mutual funds
     7,928        43        —         7,971        —    
U.S. government agency securities
     4,617        5        (12     4,610        3,296  
Certificates of deposit and time deposits
     1,356        —          —         1,356        —    
Non-U.S.
government securities
     589        —          —         589        —    
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 334,077      $ 5,477      $ (718   $ 338,836      $ 91,937  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
Reported as follows:
 
 
  
Cost
 
  
Unrealized

Gain
 
  
Unrealized

(Loss)
 
 
Fair Market

Value
 
  
Fair Market

Value of

Investments

with Unrealized

Losses
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
  
(in thousands)
 
Marketable securities
   $ 244,213      $ 64      $ (46   $ 244,231      $ 54,798  
Long-term marketable securities
     89,864        5,413        (672     94,605        37,139  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 334,077      $ 5,477      $ (718   $ 338,836      $ 91,937  
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
As of April 3, 2022, the fair market value of investments with unrealized losses less than one year and greater than one year totaled $248.2 million and $9.8 million
,
respectively. As of December 31, 2021, the fair market value of investments with unrealized losses for less than one year and greater than one year totaled $85.4 million and $6.5 million, respectively.
Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments at April 3, 2022 and December 31, 2021 were not other than temporary.
The contractual maturities of investments in
available-for-sale
securities held at April 3, 2022 were as follows:
 
 
  
April 3, 2022
 
 
  
Cost
 
  
Fair Market

Value
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Due within one year
   $ 282,563      $ 282,016  
Due after 1 year through 5 years
     36,844        35,718  
Due after 5 years through 10 years
     6,117        5,978  
Due after 10 years
     35,480        35,371  
    
 
 
    
 
 
 
Total
   $ 361,004      $ 359,083  
    
 
 
    
 
 
 
Contractual maturities of investments in
available-for-sale
securities held at April 3
, 2022
exclude debt mutual funds with a fair market value of $7.0 million, as they do not have a contractual maturity date.
 
12

Derivatives
Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities. Teradyne does not use derivative financial instruments for trading or speculative purposes.
To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings and is used to offset the change in value of monetary assets and liabilities denominated in foreign currencies.
At April 3, 2022 and December 31, 2021, Teradyne had the following contracts to buy and sell non-U.S. currencies for U.S. dollars and other non-U.S. currencies with the following notional amounts:
 
 
  
April 3, 2022
 
 
December 31, 2021
 
 
  
Buy
Position
 
 
Sell
Position
 
  
Net

Total
 
 
Buy
Position
 
 
Sell

Position
 
  
Net

Total
 
 
  
(in millions)
 
Japanese Yen
  
$
(45.9
 
$
—  
 
  
$
(45.9
 
$
(31.4
 
$
—  
 
  
$
(31.4
Taiwan Dollar
  
 
(43.7
 
 
—  
 
  
 
(43.7
 
 
(35.1
 
 
—  
 
  
 
(35.1
Korean Won
  
 
(5.0
 
 
—  
 
  
 
(5.0
 
 
(4.2
 
 
—  
 
  
 
(4.2
British Pound Sterling
  
 
(2.9
 
 
—  
 
  
 
(2.9
 
 
(1.8
 
 
—  
 
  
 
(1.8
Singapore Dollar
  
 
—  
 
 
 
75.5
 
  
 
75.5
 
 
 
—  
 
 
 
61.9
 
  
 
61.9
 
Euro
  
 
—  
 
 
 
42.3
 
  
 
42.3
 
 
 
—  
 
 
 
44.9
 
  
 
44.9
 
Philippine Peso
  
 
—  
 
 
 
3.8
 
  
 
3.8
 
 
 
—  
 
 
 
3.9
 
  
 
3.9
 
Chinese Yuan
  
 
—  
 
 
 
2.8
 
  
 
2.8
 
 
 
—  
 
 
 
2.8
 
  
 
2.8
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Total
  
$
(97.5
 
$
124.4
 
  
$
26.9
 
 
$
(72.5
 
$
113.5
 
  
$
41.0
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
The fair value of the outstanding contracts was a loss of $0.5 million and $0.1 million, respectively, at April 3, 2022 and December 31, 2021.
Gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net.
The following table summarizes the fair value of derivative instruments as of April 3, 2022 and December 31,
2021:
 
 
  
Balance Sheet Location
  
April 3,
2022
 
  
December 31,
2021
 
 
  
 
  
 
 
  
 
 
 
  
 
  
(in thousands)
 
Derivatives not designated as hedging instruments:
  
 
  
     
  
     
Foreign exchange contracts
  
Prepayments
  
$
9
 
  
$
92
 
Foreign exchange contracts
  
Other current liabilities
  
 
(469
  
 
(118
 
  
 
  
 
 
 
  
 
 
 
Total derivatives
  
 
  
$
(460
  
$
(26
 
  
 
  
 
 
 
  
 
 
 
The following table summarizes the effect of derivative instruments recognized in the statement of operations for the three months ended April 3, 2022 and April 4, 2021:
 
  
Location of (Gains) Losses
 
 
For the Three Months

Ended
 
 
  
Recognized in
Statement of Operations
 
 
April 3,
2022
 
  
April 4,
2021
 
 
  
 
 
 
 
 
  
 
 
 
  
 
 
 
(in thousands)
 
Derivatives not designated as hedging instruments:
  
     
 
     
  
     
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
     Other
 
(income) expense, net
 
 
  $ (1,752    $ 2,118  
 
(1)
The table does not reflect the corresponding gains and losses from the remeasurement of the monetary assets and liabilities denominated in foreign currencies.
(2)
For the three months ended April 3,
2022
, net losses from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $4.3 million.
(3)
For the three months ended April 4, 2021, net gains from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $0.2 million.
See Note H: “Debt” regarding derivatives related to the convertible senior notes.

13

H. DEBT
Convertible Senior Notes
On December 12,
2016
, Teradyne completed a private offering of $460.0 million aggregate principal amount of 1.25% convertible senior unsecured notes (the “Notes”) due
December 15, 2023
and received net proceeds, after issuance costs, of approximately $450.8 million, $33.0 million of which was used to pay the net cost of the convertible note hedge transactions and $50.1 million of which was used to repurchase 2.0 million shares of Teradyne’s
common stock under its existing stock repurchase
 
program
from purchasers of the Notes in privately negotiated transactions effected through one of the initial purchasers or its affiliates conducted concurrently with the pricing of the Note offering. The Notes will mature on December 15, 2023, unless earlier repurchased or converted. The Notes bear interest at a rate of
1.25
% per year
payable semiannually in arrears on June 15 and December 15 of each year
. The Notes will be convertible at the option of the noteholders at any time prior to the close of business on the business day immediately preceding September 15, 2023, only under the following circumstances: (1) during any calendar quarter beginning after
March 31, 2017
(and only during such calendar quarter), if the closing sale price of Teradyne’s common stock, for at least
20
trading days (whether or not consecutive) during a period of
30
consecutive trading days ending on the last trading day of the immediately preceding
calendar
quarter is greater than
130
% of the conversion price on each applicable trading day; (2) during the
five
business day period after any
five
consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $
1,000
principal amount of Notes for each trading day of the measurement period was less than
98
% of the product of the closing sale price of the Teradyne’s common stock and the conversion rate on each such trading day; and (3) upon the occurrence of specified corporate events. On or after
September 15, 2023
until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Notes at any time, regardless of the foregoing circumstances. Teradyne may satisfy its future conversion obligation by paying cash for the principal amount of the Notes and paying or delivering cash, shares of its common stock or a combination of cash and shares of its common stock, at Teradyne’s election for the amount in excess of principal. As of April 3, 2022, the conversion price was approximately $
31.51
per share of Teradyne’s common stock. The conversion rate is subject to adjustment under certain circumstances. As of May 6, 2022, ninety
 
eight holders had exercised the option to convert $
373.5
 million worth of notes.
Concurrent with the offering of the Notes, Teradyne entered into convertible note hedge transactions (the “Note Hedge Transactions”) with the initial purchasers or their affiliates (the “Option Counterparties”). The Note Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of the common stock that underlie the Notes, with a strike price equal to the conversion price of the Notes of $31.51.
Separately and concurrent with the pricing of the Notes, Teradyne entered into warrant transactions with the Option Counterparties (the “Warrant Transactions”) in which it sold
net-share-settled
(or, at its election subject to certain conditions, cash-settled) warrants to the Option Counterparties. The Warrant Transactions currently cover, subject to customary anti-dilution adjustments, approximately 14.6 million shares of common stock. As of April 3, 2022, the strike price of the warrants was approximately $39.54 per share. The strike price is subject to adjustment under certain circumstances. The Warrant Transactions could have a dilutive effect to Teradyne’s common stock to the extent that the market price per share of Teradyne’s common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.
The Note Hedge Transactions are expected to reduce the potential dilution to Teradyne’s common stock upon any conversion of the Notes. However, the Warrant Transactions could separately have a dilutive effect to the extent that the market value per share of Teradyne’s common stock exceeds the applicable strike price of the warrant. The net cost of the Note Hedge Transactions, after being partially offset by the proceeds from the sale of the warrants, was approximately $33.0 million.
In connection with establishing their initial hedge of these convertible note hedge and warrant transactions, the Option Counterparties have entered into various derivative transactions with respect to Teradyne’s common stock and/or purchased shares of Teradyne’s common stock or other securities, including the Notes, concurrent with, or shortly after, the pricing of the Notes. In addition, the Option Counterparties may modify their hedge positions by entering into or unwinding various derivative transactions with respect to Teradyne’s common stock or by selling Teradyne’s common stock or other securities, including the Notes, in secondary market transactions (and may do so during any observation period related to the conversion of the Notes). These activities could adversely affect the value of Teradyne’s common stock and the Notes.
Originally, Teradyne
allocated $100.8 million of the $460.0 million principal amount of the Notes to the equity component, which represent
ed
a discount to the debt and
was
amortized to interest expense using the effective interest method through December 2023. 
Effective January 1, 2022, Teradyne adopted ASC 2020-06 using the modified retrospective method of transition and accounts for the debt as a single liability measured at its amortized cost. As a result of the adoption, Teradyne recorded an increase of
$1.4 
million to current debt for unsettled shares, an increase of
$6.6 million 
to long-term debt for unamortized debt discount, and an increase to retained earnings of
$92.8 million 
for the reclassification of the equity component. Mezzanine equity representing unsettled shares value was reduced to zero and additional paid-in capital was reduced by
$99.3 million.
On November 4, 2021, Teradyne made an irrevocable election under the Indenture to require the principal portion of the remaining Notes to be settled in cash.
Debt issuance
 
fees
of approximately $0.4 million
, at April 3, 2022,
are being amortized to interest expense using the effective interest method over the seven-year term of the Notes. 
 
1
4

The below tables represent the key components of Teradyne’s convertible senior notes:
 
 
  
April 3,
2022
 
  
December 31,
2021
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Debt principal
   $ 96,285      $ 116,980  
Unamortized
debt issuance fees
(1)
     410        8,554  
    
 
 
    
 
 
 
Net carrying amount of convertible debt
   $ 95,875      $ 108,426  
    
 
 
    
 
 
 
Reported as follows:
 
 
  
April 3,
2022
 
  
December 31,
2021
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Current debt
   $ 20,497      $ 19,182  
Long-term debt
     75,378        89,244  
    
 
 
    
 
 
 
Net carrying amount of convertible debt
   $ 95,875      $ 108,426  
    
 
 
    
 
 
 
 
 
  
For the Three Months
Ended
 
 
  
April 3,
2022
 
  
April 4,
2021
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Contractual interest expense on the coupon
   $ 311      $ 1,239  
Amortization of debt
issuance
fees recognized as interest expense (
2
)
     66        3,836  
    
 
 
    
 
 
 
Total interest expense on the convertible debt
   $ 377      $ 5,075  
    
 
 
    
 
 
 
 
(1)
Unamortized debt issuance fees as of December 31, 2021 include unamortized debt discount of $8.1 million, which was eliminated with the adoption of ASU 2020-6 on January 1, 2022.
(2)
Three months ended April 4, 2021 includes the amortization of debt discount component, which was eliminated with the adoption of ASU
2020-06
on January 1, 2022.
As of April 3, 2022, the conversion price was approximately $31.51 per share and the
if-converted
value of the notes was $355.6 million.
During the three months ended April 3, 2022, eleven debt holders elected to convert $20.7 million of debt principal. The conversion of the debt was settled in cash for principal amount and in shares for the excess of conversion value over principal amount. The 0.5 million shares issued to the debt holders were received from exercising the convertible notes hedge call options.
Additional conversions of approximately $20.5 million of debt principal will occur in the second quarter of 2022 and the liability is included in current debt.
Teradyne expects to make principal interest payments of $1.2 million in the next 12 months and $1.2 million thereafter.
Revolving Credit Facility
On May 1, 2020, Teradyne entered into a credit agreement (the “Credit Agreement”) with Truist Bank, as administrative agent and collateral agent, and the lenders party thereto. The Credit Agreement provide
d
for a three-year, senior secured revolving credit facility of $400.0 million (the “Credit Facility”).
On December 10, 2021, the Credit Agreement was amended to extend maturity date of the Credit Facility to December 10, 2026. The amended Credit Agreement provides that, subject to customary conditions, Teradyne may seek to obtain from existing or new lenders the available incremental amount under the Credit Facility, not to exceed the greater of $200.0 million or 15% of consolidated EBIDTA. The interest rate applicable to loans under the Credit Facility are, at Teradyne’s option, equal to either a base rate plus a margin ranging from 0.00% to 0.75% per annum or LIBOR plus a margin ranging from 1.00% to 1.75% per annum, based on the consolidated leverage ratio of Teradyne. In addition, Teradyne will pay a commitment fee on the unused portion of the commitments under the Credit Facility ranging from 0.15% to 0.25% per annum, based on the then applicable consolidated leverage ratio.
 
1
5

Teradyne is not required to repay any loans under the Credit Facility prior to maturity, subject to certain customary exceptions. Teradyne is permitted to prepay all or any portion of the loans under the Credit Facility prior to maturity without premium or penalty, other than customary LIBOR breakage costs.
The Credit Agreement contains customary events of default, representations, warranties and affirmative and negative covenants that, among other things, limit Teradyne’s ability to sell assets, grant liens on assets, incur other secured indebtedness and make certain investments and restricted payments, all subject to exceptions set forth in the Credit Agreement. The Credit Agreement also requires Teradyne to satisfy two financial ratios measured as of the end of each fiscal quarter a consolidated leverage ratio and an interest coverage ratio.
The Credit Facility is guaranteed by certain of Teradyne’s domestic subsidiaries and collateralized by assets of Teradyne and such subsidiaries, including a pledge of 65% of the capital stock of certain foreign subsidiaries.
As of May 6, 2022, Teradyne has not borrowed any funds under the credit facility and was in compliance with all covenants. 
I. PREPAYMENTS
Prepayments consist of the following:
 
 
  
April 3,
2022
 
  
December 31,
2021
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Contract manufacturer and supplier prepayments
   $ 441,665      $ 364,478  
Prepaid maintenance and other services
     14,772        13,660  
Prepaid taxes
     10,756        15,090  
Other prepayments
     12,221        13,038  
    
 
 
    
 
 
 
Total prepayments
   $ 479,414      $ 406,266  
    
 
 
    
 
 
 
J. PRODUCT WARRANTY 
Teradyne generally provides a
one-year
warranty on its products, commencing upon installation, acceptance or shipment. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based on historical experience. Related costs are charged to the warranty accrual as incurred. The balance below is included in other accrued liabilities.​​​​​​​
 
 
 
  
For the Three Months

Ended
 
 
  
April 3,
2022
 
  
April 4,
2021
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
 
 
 
 
 
 
 
 
 
Balance at beginning of period
   $ 24,577      $ 16,633  
Accruals for warranties issued during the period
     4,100        11,881  
Accruals related to
pre-existing
warranties
     (2,758      447  
Settlements made during the period
     (5,814      (5,068
    
 
 
    
 
 
 
Balance at end of period
   $ 20,105      $ 23,893  
    
 
 
    
 
 
 
When Teradyne receives revenue for extended warranties, beyond one year, it is deferred and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. The balance below is included in short and long-term deferred revenue and customer advances.​​​​​​​​​​​​​​
 
 
  
For the Three Months

Ended
 
 
  
April 3,
2022
 
  
April 4,
2021
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
 
 
 
 
 
 
 
 
 
Balance at beginning of period
   $ 64,168      $ 51,929  
Deferral of new extended warranty revenue
     11,774        7,517  
Recognition of extended warranty deferred revenue
     (10,216      (5,538
    
 
 
    
 
 
 
Balance at end of period
   $ 65,726      $ 53,908  
    
 
 
    
 
 
 
 
16

K. STOCK-BASED COMPENSATION
Under Teradyne’s stock compensation plans, Teradyne grants service-based restricted stock units, performance-based restricted stock units and stock options, and employees are eligible to purchase Teradyne’s common stock through its Employee Stock Purchase Plan (“ESPP”).
Service-based restricted stock unit awards granted to employees vest in equal annual installments over four years. Restricted stock unit awards granted to
non-employee
directors vest after a
one-year
period, with 100% of the award vesting on the earlier of (a) the first anniversary of the grant date or (b) the date of the following year’s Annual Meeting of Shareholders. Teradyne expenses the cost of the restricted stock unit awards subject to service-based vesting, which is determined to be the fair market value of the shares at the date of grant, ratably over the period during which the restrictions lapse.
Performance-based restricted stock units (“PRSUs”) granted to Teradyne’s executive officers may have a performance metric based on relative total shareholder return (“TSR”). Teradyne’s three-year TSR performance is measured against the New York Stock Exchange (“NYSE”) Composite Index. The final number of TSR PRSUs that vest will vary based upon the level of performance achieved from 0% to 200% of the target shares. The TSR PRSUs will vest upon the three-year anniversary of the grant date. The TSR PRSUs are valued using a Monte Carlo simulation model. The number of units expected to be earned, based upon the achievement of the TSR market condition, is factored into the grant date Monte Carlo valuation. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the year following the grant. Compensation expense is recognized regardless of the eventual number of units that are earned based upon the market condition, provided the executive officer remains an employee at the end of the three-year period. Compensation expense is reversed if at any time during the three-year service period the executive officer is no longer an employee, subject to the retirement and termination eligibility provisions noted below.
PRSUs granted to Teradyne’s executive officers may also have a performance metric based on three-year cumulative
non-GAAP
profit before interest and tax (“PBIT”) as a percent of Teradyne’s revenue.
Non-GAAP
PBIT is a financial measure equal to GAAP income from operations less restructuring and other, amortization of acquired intangible assets; acquisition and divestiture related charges or credits; pension actuarial gains and losses; and other
non-recurring
gains and charges. The final number of PBIT PRSUs that vest will vary based upon the level of performance achieved from 0% to 200% of the target shares. The PBIT PRSUs will vest upon the three-year anniversary of the grant date. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant date to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the year following the grant. Compensation expense is recognized based on the number of units that are earned based upon the three-year Teradyne PBIT as a percent of Teradyne’s revenue, provided the executive officer remains an employee at the end of the three-year period subject to the
retirement and termination eligibility provisions noted below.

If
a PRSU recipient’s employment ends prior to the determination of the performance percentage due to (1) permanent disability or death or (2) retirement or termination other than for cause, after attaining both at least age sixty and at least ten years of service, then all or a portion of the recipient’s PRSUs (based on the actual performance percentage achieved on the determination date) will vest on the date the performance percentage is determined. Except as set forth in the preceding sentence, no PRSUs will vest if the executive officer is no longer an employee at the end of the three-year period.
Stock options to purchase Teradyne’s common stock at 100% of the fair market value on the grant date vest in equal annual installments over four years from the grant date and have a maximum term of seven years.
During
 the three months ended April 
3
,
2022
and April 
4
,
2021
, Teradyne granted
0.4
 million and
0.3
 million of service-based restricted stock unit awards to employees at a weighted average grant date fair value of $
111.31
and $
112.55
, respectively.
During the three months ended April 3, 2022 and April 4, 2021, Teradyne granted 0.1 million of PBIT PRSUs with a grant date fair value of $110.84 and $112.28, respectively.
During the three months ended April 3, 2022 and April 4, 2021, Teradyne granted 0.1 million of TSR PRSUs, with a grant date fair value of $101.06 and $125.02, respectively. The fair value was estimated using the Monte Carlo simulation model with the following assumptions:​​​​​​​
 
 
 
 
 
 
 
 
 
 
    
For the Three Months

Ended
 
    
April 3,
2022
   
April 4,
2021
 
Risk-free interest rate
     1.4     0.2
Teradyne volatility-historical
     47.1     43.9
NYSE Composite Index volatility-historical
     22.7     22.9
Dividend yield
     0.4     0.4
 
17

Expected
 
volatility was based on the historical volatility of Teradyne’s stock and the NYSE Composite Index over the most recent three-year period. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $
0.44
per share divided by Teradyne’s stock price on the grant date of $
112.12
for the 2022 grant and an estimated annual dividend amount of $
0.40
per share divided by Teradyne’s stock price on the grant date of $
113.48
for the 2021 grant.
During the three months ended April 3, 2022 and April 4, 2021, Teradyne granted 0.1 million of service-based stock options to executive officers at a weighted average grant date fair value of $39.01 and $36.60, respectively.
The fair value of stock options was estimated using the Black-Scholes option-pricing model with the following assumptions:
 
 
 
 
 
 
 
 
 
 
    
For the Three Months

Ended
 
    
April 3,
2022
   
April 4,
2021
 
Expected life (years)
     4.0       5.0  
Risk-free interest rate
     1.6     0.4
Volatility-historical
     43.7     37.8
Dividend yield
     0.4     0.4
Teradyne determined the stock options’ expected life based upon historical exercise data for executive officers, the age of the executive officers and the terms of the stock option grant. Volatility was determined using historical volatility for a period equal to the expected life. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $0.44 per share divided by Teradyne’s stock price on the grant date of $112.12 for the 2022 grant and an estimated annual dividend amount of $0.40 per share divided by Teradyne’s stock price on the grant date of $113.48 for the 2021 grant.
L. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Changes in accumulated other comprehensive income (loss), which are presented net of tax, consist of the following:
 
 
  
Foreign

Currency

Translation

Adjustment
 
  
Unrealized

Gains

(Losses) on

Marketable

Securities
 
  
Retirement

Plans Prior

Service

Credit
 
  
Total
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Three Months Ended April 3, 2022
  
  
  
  
Balance at December 31, 2021, net of tax of $0, $1,055, $(1,128), respectively
   $ (10,818    $ 3,704      $ 1,166      $ (5,948
Other comprehensive loss before reclassifications, net of tax of $0, $(1,333), $0, respectively
     (8,076      (5,388      —          (13,464
Amounts reclassified from accumulated other comprehensive income, net of tax of $0, $(18), $0, respectively
     —          (65      (2      (67
    
 
 
    
 
 
    
 
 
    
 
 
 
Net current period other comprehensive loss, net of tax of $0, $(1,351), $0, respectively
     (8,076      (5,453      (2      (13,531
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance at April 3, 2022, net of tax of $0, $(296), $(1,128), respectively
   $ (18,894    $ (1,749    $ 1,164      $ (19,479
    
 
 
    
 
 
    
 
 
    
 
 
 
Three Months Ended April 4, 2021
                                   
Balance at December 31, 2020, net of tax of $0, $1,910, $(1,126), respectively
   $ 25,389      $ 6,954      $ 1,173      $ 33,516  
Other comprehensive loss before reclassifications, net of tax of $0, $(908), $0, respectively
     (21,123      (3,270      —          (24,393
Amounts reclassified from accumulated other comprehensive income, net of tax of $0, $(123), $0, respectively
     —          (444      (2      (446
    
 
 
    
 
 
    
 
 
    
 
 
 
Net current period other comprehensive loss, net of tax of $0, $(1,031), $0, respectively
     (21,123      (3,714      (2      (24,839
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance at April 4, 2021, net of tax of $0, $879, $(1,126), respectively
   $ 4,266      $ 3,240      $ 1,171      $ 8,677  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
18
Reclassifications out of accumulated other comprehensive income (loss) to the statement of operations for the three months ended April 3, 2022 and April 4, 2021 were as follows:
 
Details about Accumulated Other Comprehensive Income (Loss) Components
  
For the Three Months

Ended
 
  
Affected Line Item

in the Statements

of Operations
 
 
  
 
 
  
 
 
  
 
 
 
  
April 3,
 
  
April 4,
 
  
 
 
 
  
2022
 
  
2021
 
  
 
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
  
 
 
Available-for-sale
marketable securities:
  
  
  
Unrealized gains, net of tax of $18 and $123, respectively

   $ 65      $ 444     
 
Other (income)
expense, net
 
Defined benefit pension and postretirement plans:
                    
 
 
 
Amortization of prior service
cre
dit
, net of tax of $0 and $0, respectively
     2        2     
 
(a)
 
    
 
 
    
 
 
    
 
 
 
Total reclassifications, net of tax of $18 and $123, respectively
   $ 67      $ 446     
 
Net income
 
    
 
 
    
 
 
    
 
 
 
 
(a)
The amortization of prior service credit is included in the computation of net periodic postretirement benefit cost. See Note
P
: “Retirement Plans.”
M. GOODWILL AND ACQUIRED INTANGIBLE ASSETS
Goodwill
Teradyne performs its annual goodwill impairment test as required under the provisions of ASC
350-10,
“Intangibles—Goodwill and Other”
on December 31 of each fiscal year unless interim indicators of impairment exist. In the three months ended April 3, 2022
,
there were no interim indicators of impairment. Goodwill is considered impaired when the net book value of a reporting unit exceeds its estimated fair value.

The changes in the carrying amount of goodwill by reportable segments for the three months ended April 3, 2022, were as follows:
 
 
  
Industrial

Automation
 
  
Wireless

Test
 
  
Semiconductor

Test
 
  
System

Test
 
  
Total
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Balance at December 31, 2021
  
     
  
     
  
     
  
     
  
     
Goodwill
   $ 405,971     $ 361,819     $ 262,101     $ 158,699     $ 1,188,590  
Accumulated impairment losses
     —         (353,843     (260,540     (148,183     (762,566
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total goodwill
     405,971       7,976       1,561       10,516       426,024  

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustment
     (6,122     —         (14     —         (6,136
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at April 3, 2022
                                        
Goodwill
     399,849       361,819       262,087       158,699       1,182,454  
Accumulated impairment losses
     —         (353,843     (260,540     (148,183     (762,566
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total goodwill
   $ 399,849     $ 7,976     $ 1,547     $ 10,516     $ 419,888  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Intangible Assets
Teradyne reviews long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate.
Amortizable intangible assets consist of the following and are included in intangible assets, net on the balance sheet:
 
 
  
Gross

Carrying

Amount
 
  
Accumulated

Amortization
 
  
Foreign Currency
Translation
Adjustment
 
  
Net

Carrying

Amount
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Balance at April 3, 2022
  
     
  
     
  
     
  
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Developed technology
   $ 272,547      $ (226,648    $ (4,565    $ 41,334  
Customer relationships
     57,739        (49,492      194        8,441  
Tradenames and trademarks
     59,387        (38,494      (822      20,071  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total intangible assets
   $ 389,673      $ (314,634    $ (5,193    $ 69,846  
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance, December 31, 2021
                                   
Developed technology
   $ 272,547      $ (223,413    $ (4,093    $ 45,041  
Customer relationships
     57,739        (48,921      209        9,027  
Tradenames and trademarks
     59,387        (37,237      (583      21,567  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total intangible assets
   $ 389,673      $ (309,571    $ (4,467    $ 75,635  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
19

Aggregate
 
intangible asset amortization expense for the three months ended April 3, 2022 and April 4, 2021 was $
5.1
 million and $
5.5
 million, respectively.
Estimated intangible asset amortization expense for each of the five succeeding fiscal years
and thereafter
is as follows:
 
 
 
 
 
 
Year
  
Amortization Expense
 
    
(in thousands)
 
2022
   $ 14,879  
2023
     19,377  
2024
     19,069  
2025
     11,456  
2026
     2,404  
Thereafter
     2,661  
N. NET INCOME PER COMMON SHARE
The following table sets forth the computation of basic and diluted net income per common share:
 
 
  
For the Three Months

Ended
 
 
  
April 3,
 
  
April 4,
 
 
  
2022
 
  
2021
 
 
  
 
 
  
 
 
 
  
(in thousands, except per share amounts)
 
 
 
 
 
 
 
 
 
 
Net income for basic and diluted net income per share
   $ 161,928      $ 205,512  
    
 
 
    
 
 
 
Weighted average common shares-basic
     162,048        166,491  
Effect of dilutive potential common shares:
                 
Convertible note hedge warrant shares (1)
     10,028        9,429  
Incremental shares from assumed conversion of convertible notes (2)
     2,541        10,310  
Restricted stock units
     875        1,395  
Stock options
     69        108  
Employee stock purchase plan
     14        7  
    
 
 
    
 
 
 
Dilutive potential common shares
     13,527        21,249  
    
 
 
    
 
 
 
Weighted average common shares-diluted
     175,575        187,740  
    
 
 
    
 
 
 
Net income per common share-basic
   $ 1.00      $ 1.23  
    
 
 
    
 
 
 
Net income per common share-diluted
   $ 0.92      $ 1.09  
    
 
 
    
 
 
 
 
(1)
Convertible notes hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price of $39.54, multiplied by 14.6 million shares. The result of this calculation, representing the total intrinsic value of the warrant, was divided by the average Teradyne stock price for the period.
(2)
Incremental shares from assumed conversion of the convertible notes were calculated using the difference between the average Teradyne stock price for the period and the conversion price of $31.51, multiplied by 3.4 million shares. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period.
The computation of diluted net income per common share for the three months ended April 3, 2022 and April 4, 2021 excludes the effect of the potential vesting of 0.1 million and 0.1 million, respectively, of restricted stock units because the effect would have been anti-dilutive.
O. RESTRUCTURING AND OTHER
During the three months ended April 3, 2022, Teradyne recorded a charge of $14.7 
million related to the arbitration claim filed against Teradyne and AutoGuide related to an earn-out dispute, which was settled
on
 March
 25,
2022 for $26.7 million. Previously, in the three months ended December 31, 2021, Teradyne recorded a charge of $12.0 million related to this earn-out dispute. 
During the three months ended April 4, 2021, Teradyne recorded a gain of $7.2 
million for the decrease in the fair value of the AutoGuide contingent consideration liability. 
 
20
P. RETIREMENT PLANS
ASC 715, “Compensation—Retirement Benefits,” requires an employer with defined benefit plans or other postretirement benefit plans to recognize an asset or a liability on its balance sheet for the overfunded or underfunded status of the plans as defined by ASC 715. The pension asset or liability represents a difference between the fair value of the pension plan’s assets and the projected benefit obligation at December 31. Teradyne uses a December 31 measurement date for all of its plans.
Defined Benefit Pension Plans
Teradyne has defined benefit pension plans covering a portion of domestic employees and employees of certain
non-U.S.
subsidiaries. Benefits under these plans are based on employees’ years of service and compensation. Teradyne’s funding policy is to make contributions to these plans in accordance with local laws and to the extent that such contributions are tax deductible. The assets of the U.S. qualified pension plan consist primarily of fixed income and equity securities. In addition, Teradyne has an unfunded supplemental executive defined benefit plan in the United States to provide retirement benefits in excess of levels allowed by the Employment Retirement Income Security Act (“ERISA”) and the Internal Revenue Code (the “IRC”), as well as unfunded qualified foreign plans.
In the
 
three
months ended April 
3
,
2022
and April 
4
,
2021
, Teradyne contributed $
0.8
 million and $
0.8
 million, respectively, to the U.S. supplemental executive defined benefit pension plan
,
and $
0.3
 million and $
0.3
 million, respectively, to certain qualified pension plans for
non-U.S.
subsidiaries.
For the three months ended April 3, 2022 and April 4, 2021, Teradyne’s net periodic pension cost was comprised of the following:
 
 
  
For the Three Months Ended
 
 
  
April 3,

2022
 
  
April 4,

2021
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
United States
 
  
Foreign
 
  
United States
 
  
Foreign
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Service cost
   $ 397      $ 206      $ 453      $ 243  
Interest cost
     1,222        118        1,100        87  
Expected return on plan assets
     (732      (20      (936      (16
    
 
 
    
 
 
    
 
 
    
 
 
 
Total net periodic pension cost
   $ 887      $ 304      $ 617      $ 314  
    
 
 
    
 
 
    
 
 
    
 
 
 
Postretirement Benefit Plan
In addition to receiving pension benefits, Teradyne employees in the United States who meet early retirement eligibility requirements as of their termination dates may participate in Teradyne’s Welfare Plan, which includes medical and dental benefits up to age 65. Death benefits provide a fixed sum to retirees’ survivors and are available to all retirees. Substantially all of Teradyne’s current U.S. employees could become eligible for these benefits, and the existing benefit obligation relates primarily to those employees.
For the three months ended April 3, 2022 and April 4, 2021, Teradyne’s net periodic postretirement benefit cost was comprised of the following:
 
 
  
For the Three Months

Ended
 
 
  
April 3,
2022
 
  
April 4,
2021
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Service cost
   $ 17      $ 16  
Interest cost
     44        44  
Amortization of prior service credit
     (2      (2
    
 
 
    
 
 
 
Total net periodic postretirement benefit cost
   $ 59      $ 58  
    
 
 
    
 
 
 
 
21

Q. COMMITMENTS AND CONTINGENCIES
Purchase Commitments
As of April 3, 2022, Teradyne had entered into purchase commitments for certain components and materials. The purchase commitments covered by the agreements aggregate to approximately $904.0 million, of which $826.7 million is for less than one year.
Legal Claims
Teradyne is subject to various legal proceedings and claims which have arisen in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. Teradyne believes that it has meritorious defenses against all pending claims and intends to vigorously contest them. While it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, Teradyne believes the potential losses associated with all of these actions are unlikely to have a material adverse effect on its business, financial position or results of operations.
On March 8, 2021, Industrial Automation LLC, sellers of AutoGuide, submitted a demand for arbitration against Teradyne and AutoGuide in Wilmington, Delaware alleging that Teradyne and AutoGuide breached certain provisions of the Membership Interests Purchase Agreement (the “Purchase Agreement”), dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide. The arbitration demand sought
ful
l acceleration of the maximum earn-out amount payable under the Purchase Agreement, or $106.9
million, for the alleged breach of the earn-out provisions of the Purchase Agreement. On March 21, 2022, the arbitration claim was settled for
$26.7 
million. As a result, Teradyne has no remaining earn-
out
obligations. 

Guarantees and Indemnification Obligations
Teradyne provides indemnification, to the extent permitted by law, to its officers, directors, employees and agents for liabilities arising from certain events or occurrences, while the officer, director, employee, or agent, is or was serving, at Teradyne’s request in such capacity. Teradyne may enter into indemnification agreements with certain of its officers and directors. With respect to acquisitions, Teradyne provides indemnifications to or assumes indemnification obligations for the current and former directors, officers and employees of the acquired companies in accordance with the acquired companies’ by-laws and charter. As a matter of practice, Teradyne has maintained directors’ and officers’ liability insurance coverage including coverage for directors and officers of acquired companies.
Teradyne enters into agreements in the ordinary course of business with customers, resellers, distributors, integrators and suppliers. Most of these agreements require Teradyne to defend and/or indemnify the other party against intellectual property infringement claims brought by a third party with respect to Teradyne’s products. From time to time, Teradyne also indemnifies customers and business partners for damages, losses and liabilities they may suffer or incur relating to personal injury, personal property damage, product liability, breach of confidentiality obligations and environmental claims relating to the use of Teradyne’s products and services or resulting from the acts or omissions of Teradyne, its employees, authorized agents or subcontractors. On occasion, Teradyne has also provided guarantees to customers regarding the delivery and performance of its products in addition to the warranty described below.
As a matter of ordinary course of business, Teradyne warrants that its products will substantially perform in accordance with its standard published specifications in effect at the time of delivery. Most warranties have a one-year duration commencing from installation. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based upon historical experience. When Teradyne receives revenue for extended warranties beyond the standard duration, the revenue is deferred and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. As of April 3, 2022 and December 31, 2021, Teradyne had a product warranty accrual of $20.1 million and $24.6 million, respectively, included in other accrued liabilities, and revenue deferrals related to extended warranties of $65.7 million and $64.2 million, respectively, included in short and long-term deferred revenue and customer advances.
In addition, in the ordinary course of business, Teradyne provides minimum purchase guarantees to certain vendors to ensure continuity of supply against the market demand. Although some of these guarantees provide penalties for cancellations and/or modifications to the purchase commitments as the market demand decreases, most of the guarantees do not. Therefore, as the market demand decreases, Teradyne re-evaluates these guarantees and determines what charges, if any, should be recorded.
With respect to its agreements covering product, business or entity divestitures and acquisitions, Teradyne provides certain representations, warranties and covenants to purchasers and agrees to indemnify and hold such purchasers harmless against breaches of such representations, warranties and covenants. Many of the indemnification claims have a definite expiration date while some remain in force indefinitely. With respect to its acquisitions, Teradyne may, from time to time, assume the liability for certain events or occurrences that took place prior to the date of acquisition.
 
 
22

As a matter of ordinary course of business, Teradyne occasionally guarantees certain indebtedness obligations of its subsidiary companies, limited to the borrowings from financial institutions, purchase commitments to certain vendors, and lease commitments to landlords.
Based on historical experience and information known as of April 3, 2022 and December 31, 2021, except for product warranty, Teradyne has not recorded any liabilities for these guarantees and obligations because the amount would be immaterial.
R. INCOME TAXES
A reconciliation of the United States federal statutory corporate tax rate to Teradyne’s effective tax rate was as follows:
 
 
  
For the Three Months

Ended
 
 
  
April 3,
2022
 
 
April 4,
2021
 
 
  
 
 
 
 
 
US statutory federal tax rate
     21.0     21.0
Non-deductible
officers’ compensation
     1.1       0.8  
Discrete benefit related to equity compensation
     (6.6     (6.2
Foreign taxes
     (3.4     (4.7
Tax credits
     (1.6     (1.3
International provisions of the U.S. Tax Cuts and Jobs Act of 2017
     (1.3     (1.5
Other, net
     1.0       0.2  
    
 
 
   
 
 
 
Effective tax rate
     10.2     8.3
    
 
 
   
 
 
 
On a quarterly basis, Teradyne evaluates the realizability of the deferred tax assets by jurisdiction and assesses the need for a valuation allowance. As of April 3, 2022, Teradyne believes that it will ultimately realize the deferred tax assets recorded on the condensed consolidated balance sheet. However, should Teradyne believe that it is
more-likely-than-not
that the deferred tax assets would not be realized, the tax provision would increase in the period in which Teradyne determined that the realizability was not likely. Teradyne considers the probability of future taxable income and historical profitability, among other factors, in assessing the realizability of the deferred tax assets.
As of April 3, 2022 and December 31, 2021, Teradyne had $14.6 million and $14.5 million, respectively, of reserves for uncertain tax positions. The $0.1 million net increase in reserves for uncertain tax positions is related to U.S. federal research and development credits generated in the current year.
As of April 3, 2022, Teradyne estimates that it is reasonably possible that the balance of unrecognized tax benefits may decrease approximately $0.2 million in the next twelve months because of a lapse of statutes of limitation. The estimated decrease relates to loss carryforwards.
Teradyne recognizes interest and penalties related to income tax matters in income tax expense. As of April 3, 2022 and December 31, 2021, $0.3 million and $0.3 million, respectively, of interest and penalties were accrued for uncertain tax positions. For the three months ended April 3, 2022 and April 4, 2021, expense of $0.1 million and $0.1 million, respectively, was recorded for interest and penalties related to income tax items.
Teradyne qualifies for a tax holiday in Singapore by fulfilling the requirements of an agreement with the Singapore Economic Development Board under which certain headcount and spending requirements must be met. The tax savings due to the tax holiday for the three months ended April 3, 2022 was $3.5 million, or $0.02 per diluted share. The tax savings due to the tax holiday for the three months ended April 4, 2021 was $6.2 million, or $0.03 per diluted share. In November 2020, Teradyne entered into an agreement with the Singapore Economic Development Board which extended our Singapore tax holiday under substantially similar terms to the agreement which expired on December 31, 2020. The new tax holiday is scheduled to expire on December 31, 2025.
S. SEGMENT INFORMATION
Teradyne has four reportable segments (Semiconductor Test, System Test, Industrial Automation and Wireless Test). Each of the reportable segments is also an individual operating segment.
 
 
23

The Semiconductor Test segment includes operations related to the design, manufacturing and marketing of semiconductor test products and services. The System Test segment includes operations related to the design, manufacturing and marketing of products and services for defense/aerospace instrumentation test, storage and system level test, and circuit-board test. The Industrial Automation segment includes operations related to the design, manufacturing and marketing of collaborative robotic arms, autonomous mobile robots and advanced robotic control software. The Wireless Test segment includes operations related to the design, manufacturing and marketing of wireless test products and services. Each operating segment has a segment manager who is directly accountable to and maintains regular contact with Teradyne’s chief operating decision maker (Teradyne’s chief executive officer) to discuss operating activities, financial results, forecasts, and plans for the segment.​​​​​​​
Teradyne evaluates performance based on several factors, of which the primary financial measure is business segment income (loss) before income taxes. The accounting policies of the business segments in effect are described in Note B: “Accounting Policies” in Teradyne’s Annual Report on Form
10-K
for the year ended December 31, 2021.
Segment information for the three months ended April 3, 2022 and April 4, 2021 is as follows:
 
 
  
Semiconductor

Test
 
  
System

Test
 
  
Industrial

Automation
 
 
Wireless

Test
 
  
Corporate

and

Eliminations
 
 
Consolidated
 
 
  
 
 
  
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
  
(in thousands)
 
Three Months Ended April 3, 2022
  
     
  
     
  
     
 
     
  
     
 
     
Revenues
   $ 482,341      $ 118,668      $ 103,189     $ 51,518      $ (346 )   $ 755,370  
Income (loss) before income taxes (1)(2)
     149,705        41,322        (5,098     18,619        (24,189     180,359  
Total assets (3)
     1,296,070        187,283        675,560       113,821        1,336,420       3,609,154  
Three Months Ended April 4, 2021
                                                   
Revenues
   $ 528,063      $ 132,837      $ 79,951     $ 40,898      $ (143   $ 781,606  
Income (loss) before income taxes (1)(2)
     176,368        51,061        (12,967     9,616        (85     223,993  
Total assets (3)
     1,243,358        179,195        672,596       104,367        1,520,201       3,719,717  
 
(1)
Included in Corporate and Eliminations are: legal fees, contingent consideration fair value adjustments, interest income, interest expense, severance charges, net foreign exchange gains (losses), acquisition related charges and compensation, intercompany eliminations and for the three months ended April 4, 2021, loss on convertible debt conversions.
(2)
Included in income (loss) before taxes are charges and credits related to restructuring and other, inventory charges and, for the three months ended April 4, 2021, loss on convertible debt conversions.
(3)
Total assets are attributable to each segment. Corporate assets consist of cash and cash equivalents, marketable securities, and certain other assets.

Included in each segment are charges and credits in the following line items in the statements of operations:
 
 
  
For the Three Months

Ended
 
 
  
April 3,
2022
 
  
April 4,
2021
 
 
  
 
 
  
 
 
 
  
(in thousands)
 
Semiconductor Test:
  
     
  
     
 
 
 
 
 
 
 
 
 
Cost of revenues—inventory charge
   $
 
 
     $ 1,079  
Industrial Automation:
                 
Cost of revenues—inventory charge
   $
 
 
     $ 1,221  
Wireless:
                 
Cost of revenues—inventory charge
   $ 877      $ —    
Corporate and
Eliminations
:
                 
Restructuring and other—
legal
settlement
 charge
   $ 14,700      $ —    
Restructuring and other—AutoGuide contingent consideration adjustment
     —          (7,227
Other (income) expense, net—loss on convertible debt conversion
s
     —          4,069  
Restructuring and other—acquisition related expenses and compensation
     —          (513
 
 
24

T. SHAREHOLDERS’ EQUITY
Stock Repurchase Program
In January 2021, Teradyne’s Board of Directors cancelled the January 2020 repurchase program and approved a new repurchase program for up to $2.0 billion of common stock. Teradyne intends to repurchase a minimum of $750.0 million of its common stock
in
2022.
During
the three months ended April 3, 2022, Teradyne repurchased 1.8 million shares of common stock for $201.5 million at an average price of $115.12 per share. During the three months ended April 4, 2021, Teradyne repurchased 0.4 million shares of common stock for $45.2 million at an average price of $120.73 per share. The cumulative repurchases under the $2.0 billion common stock repurchase program as of April 3, 2022 were 6.5 million shares of common stock for $801.5 million at an average price per share of $122.89. 

The total price includes commissions and is recorded as a reduction to retained earnings.
Dividend
Holders of Teradyne’s common stock are entitled to receive dividends when they are declared by Teradyne’s Board of Directors.
In January 2022, Teradyne’s Board of Directors declared a 10% increase in the quarterly cash dividend to $0.11 per share. Dividend payments for the three months ended April 3, 2022 were $17.9 million. In January 2021, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the three months ended April 4, 2021 were $16.7 million.
While Teradyne declared a quarterly cash dividend and authorized a share repurchase program, it may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of Teradyne’s Board of Directors which will consider, among other things, Teradyne’s earnings, capital requirements and financial condition.
 
25

Item 2:
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Statements in this Quarterly Report on Form
10-Q
which are not historical facts, so called “forward-looking statements,” are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those detailed in our filings with the Securities and Exchange Commission. See also Part II, Item 1A of this Quarterly Report on Form
10-Q
and Part I, Item 1A “Risk Factors” in our Annual Report on Form
10-K
for the year ended December 31, 2021. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.
Overview
We are a leading global supplier of automation equipment for test and industrial applications. We design, develop, manufacture and sell automatic test systems used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including the consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Our industrial automation products include collaborative robotic arms, autonomous mobile robots (“AMRs”) and advanced robotic control software used by global manufacturing, logistics and light industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Our automatic test equipment and industrial automation products and services include:
 
   
semiconductor test (“Semiconductor Test”) systems;
 
   
storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”);
 
   
wireless test (“Wireless Test”) systems; and
 
   
industrial automation (“Industrial Automation”) products.
The market for our test products is concentrated with a limited number of significant customers accounting for a substantial portion of the purchases of test equipment. A few customers drive significant demand for our test products both through direct sales and sales to the customers’ supply partners. We expect that sales of our test products will continue to be concentrated with a limited number of significant customers for the foreseeable future.
In 2022, we expect lower demand in the mobility segment of our Semiconductor Test business due to a slower technology transition in one of our largest
end-markets.
We expect this demand to accelerate in 2023 as a result of the expected ramp in 3 nanometer volume production. We also expect demand in the automotive segment to strengthen through 2022.
Our Industrial Automation segment consists of Universal Robots A/S (“UR”), a leading supplier of collaborative robotic arms, Mobile Industrial Robots A/S (“MiR”), a leading maker of AMRs for industrial automation and AutoGuide, LLC (“AutoGuide”), a maker of high payload AMRs. The market for our Industrial Automation segment products is dependent on the adoption of new automation technologies by large manufacturers as well as small and medium enterprises (SMEs) throughout the world.
We expect our UR and MiR businesses to continue to grow in 2022, while our AutoGuide business will focus on continuing to invest to scale and integrate high payload AMR solutions. Both our test and industrial automation businesses will continue to be impacted by supply constraints which will in turn impact our revenue and may, along with inflation, increase costs in 2022.
Our corporate strategy continues to focus on profitably gaining market share in our test businesses through the introduction of differentiated products that target expanding segments and accelerating growth through continued investment in our Industrial Automation businesses. We plan to execute on our strategy while balancing capital allocations between returning capital to our shareholders through stock repurchases and dividends and using capital for opportunistic acquisitions.
Impact of the
COVID-19
Pandemic on our Business
The novel coronavirus
(COVID-19)
pandemic resulted in government authorities implementing numerous measures in an effort to contain the spread of the virus, such as travel bans and restrictions, limitations on gatherings or social distancing requirements, quarantines,
shelter-in-place
orders, vaccination and testing mandates, and business limitations and shutdowns. These measures have impacted our
day-to-day
operations and disrupted our business, workforce and operations, as well as the operations of our customers, contract manufacturers and suppliers. We are continuing to monitor the rapidly evolving situation regarding the
COVID-19
pandemic particularly in China and the availability and impact of vaccinations globally. However, we are unable to accurately predict the full
 
26

Table of Contents
impact of
COVID-19,
which will depend on future developments that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, any new surges or new strains or variants of the virus in areas where we do business, the availability and use of vaccinations, any further government actions to contain the virus or treat its impact, continuing shutdowns in China, and how quickly and to what extent normal economic and operating conditions can resume.
Due to the
COVID-19
pandemic, there has been uncertainty and disruption in the global economy and our markets. We are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of May 6, 2022, the date of issuance of this Quarterly Report on Form
10-Q.
Health and Safety
In response to the
COVID-19
pandemic, we have taken proactive, aggressive action to protect the health and safety of our employees, customers, contract manufacturers and suppliers and we have complied with all government orders around the globe. The spread of
COVID-19
has caused us to modify our business practices, including implementing social distancing protocols, suspending employee travel, requiring employees to work remotely and cancelling physical participation in meetings. We may take further actions as may be required or recommended by government authorities or that we determine are in the best interests of our employees, customers, contract manufacturers and suppliers.
Operations
We believe the
COVID-19
pandemic, and the numerous measures implemented by authorities in response, has adversely impacted our results of operations, including by increasing costs, but we cannot accurately estimate the amount of the impact to our first quarter of 2022 financial results or to our future financial results. In addition, the pandemic has disrupted our contract manufacturers and suppliers, and has resulted in supply constraints and in short-term cost increases to meet customer demand. While the duration and severity of the pandemic may further impact our workforce and operations, as well as those of our customers, contract manufacturers and suppliers, we expect that our manufacturing facilities will remain operational, at sufficient capacity to support production demand. We are monitoring our operations closely in an effort to avoid any potential productivity loss caused by responses to the
COVID-19
pandemic.
Supply
We have experienced interruptions to our supply chain as a result of the
COVID-19
pandemic. Our suppliers have faced and may continue to face difficulties maintaining operations in light of
COVID-19
disruptions and government-ordered restrictions. Our supply chain team, and our suppliers, continue to manage numerous supply, production, and logistics obstacles caused by the pandemic. There is no assurance that these efforts will be successful. The
COVID-19
pandemic may continue to disrupt our ability to obtain components required to manufacture our products, adversely affecting our operations and in some instances resulting in higher costs and delays, both for obtaining components and shipping finished goods to customers.
Demand
The
COVID-19
pandemic has significantly increased economic uncertainty in our markets. Demand for our Test products in China and other countries was strong throughout 2021 and in the first quarter of 2022. The
COVID-19
pandemic could cause further economic disruption that could cause demand for our products to decline, which would adversely affect our business.
Liquidity
Although there is continued uncertainty related to the impact of the
COVID-19
pandemic on our future results, we believe our business model and our current cash reserves leave us well-positioned to manage our business through this crisis. We have a strong balance sheet as well as an operating model that we believe is capable of flexing up and down with extreme demand swings while still remaining profitable. Based on our analysis, we believe our existing balances of cash and cash equivalents and our currently anticipated operating cash flows will be sufficient to meet our working capital needs and other capital and liquidity requirements for the next twelve months. However, due to the uncertainty related to the future impact of the
COVID-19
pandemic, in order to bolster our liquidity position, on May 1, 2020 we entered into a credit agreement providing for a three-year, senior secured revolving credit facility of $400 million. On December 10, 2021, we amended the credit agreement to extend its maturity to December 10, 2026 as further described in Note H: “Debt.” As of May 6, 2022, we have not borrowed any funds under the credit facility.
We are continuing to monitor the evolving situation regarding the
COVID-19
pandemic, the availability of vaccinations where we do business and guidance from government authorities around the world. In these circumstances, there may be developments outside our control requiring us to adjust our operating plan. As a result, given the uncertain nature of this situation, we are not able to accurately predict the full extent of the impact of
COVID-19
on our business, financial condition, results of operations, liquidity, or cash flows in the future.
 
27

Table of Contents
Impact of Russia’s invasion of Ukraine on our Business
We currently do not expect a significant impact on our results of operations in the future due to Russia’s invasion of Ukraine, as we have minimal business in Russia and Ukraine, both directly and indirectly. However, following the invasion, the U.S. and other countries imposed significant sanctions against the Russian government and many Russian companies and individuals. Although Teradyne does not have significant operations in Russia, the sanctions could impact Teradyne’s business in other countries and could have a negative impact on the Company’s future revenue and supply chain, either of which could adversely affect Teradyne’s business and financial results.
See Part II—Item 1A, “Risk Factors,” included in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2021 for our risk factors regarding risks associated with both the
COVID-19
pandemic and international conflicts.
Critical Accounting Policies and Estimates
We have identified the policies which are critical to understanding our business and our results of operations. There have been no significant changes during the three months ended April 3, 2022 to the items disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2021, except as noted below.
Critical accounting estimates are complex and may require significant judgment by management. Changes to the underlying assumptions may have a material impact on our financial condition and results of operations. These estimates may change, as new events occur, and additional information is obtained. Actual results could differ significantly from these estimates under different assumptions or conditions.
Convertible Debt
We adopted Accounting Standards Update (“ASU”) ASU
2020-06
“Debt—Debt with Conversion and Other Options and Derivatives and Hedging—Contracts in Entity’s Own Equity,”
on January 1, 2022 using the modified retrospective method of adoption
.
Under ASU
2020-06,
we account for a convertible debt instrument as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Unsettled shares are recorded in current debt, and there is no recognition of a debt discount, which was previously amortized to interest expense. We use the
if-converted
method in the diluted EPS calculation for convertible instruments. As a result of adoption, we recorded an increase of $1.4 million to current debt for unsettled shares, an increase of $6.6 million to long-term debt for unamortized debt discount, and an increase to retained earnings of $92.8 million for the reclassification of the equity component. Mezzanine equity representing unsettled shares value was reduced to zero and additional
paid-in
capital was reduced by $99.3 million.
Preparation of Financial Statements and Use of Estimates
The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts reported in the financial statements. Actual results may differ significantly from these estimates under different assumptions or conditions.
 
28

Table of Contents
SELECTED RELATIONSHIPS WITHIN THE CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
 
    
For the Three Months

Ended
 
    
April 3,
2022
   
April 4,
2021
 
              
Percentage of revenues:
    
Revenues:
    
Products
     83     85
Services
     17       15  
  
 
 
   
 
 
 
Total revenues
     100       100  
Cost of revenues:
    
Cost of products
     32       34  
Cost of services
     8       7  
  
 
 
   
 
 
 
Total cost of revenues (exclusive of acquired intangible
assets amortization shown separately below)
     40       41  
  
 
 
   
 
 
 
Gross profit
     60       59  
Operating expenses:
    
Selling and administrative
     19       17  
Engineering and development
     14       13  
Acquired intangible assets amortization
     1       1  
Restructuring and other
     2       (1
Total operating expenses
     36       29  
  
 
 
   
 
 
 
Income from operations
     25       30  
Non-operating
(income) expense:
    
Interest income
     —         —    
Interest expense
     —         1  
Other (income) expense, net
     1       —    
  
 
 
   
 
 
 
Income before income taxes
     24       29  
Income tax provision
     2       2  
  
 
 
   
 
 
 
Net income
     21     26
  
 
 
   
 
 
 
Results of Operations
First Quarter 2022 Compared to First Quarter 2021
Revenues
Revenues by our reportable segments were as follows:
 
    
April 3,
2022
    
April 4,
2021
    
Dollar
Change
 
                      
    
(in millions)
 
Semiconductor Test
   $ 482.3      $ 528.1      $ (45.8
System Test
     118.7        132.8        (14.1
Industrial Automation
     103.2        80.0        23.2  
Wireless Test
     51.5        40.9        10.6  
  
 
 
    
 
 
    
 
 
 
   $ 755.4      $ 781.7      $ (26.3
  
 
 
    
 
 
    
 
 
 
The decrease in Semiconductor Test revenues of $45.8 million, or 8.7%, was driven primarily by lower tester sales in high performance compute processor and industrial applications and lower memory test sales of flash memory testers. The decrease in System Test revenues of $14.1 million, or 10.6%, was primarily due to lower sales in Storage Test of system level and hard disk drive testers, partially offset by greater sales in Defense/Aerospace and Production Board Test. The increase in Industrial Automation revenues of $23.2 million, or 29.0%, was driven primarily by higher demand for collaborative robotic arms and MiR’s autonomous mobile robots. The rise in Wireless Test revenues of $10.6 million, or 25.9%, was primarily due to increase in connectivity test products and higher demand in ultra-wide band wireless test.
 
29

Table of Contents
Revenues by country as a percentage of total revenues were as follows (1):
 
    
For the Three Months

Ended
 
    
April 3,
2022
   
April 4,
2021
 
              
China
     19     19
Taiwan
     18       33  
United States
     15       10  
Korea
     13       8  
Europe
     10       7  
Japan
     6       3  
Malaysia
     5       4  
Thailand
     5       7  
Singapore
     4       3  
Philippines
     2       4  
Rest of World
     3       2  
  
 
 
   
 
 
 
     100     100
  
 
 
   
 
 
 
 
(1)
Revenues attributable to a country are based on location of customer site.
Gross Profit
Our gross profit was as follows:
 
    
For the Three Months

Ended
       
    
April 3,
2022
   
April 4,
2021
   
Dollar/Point
Change
 
                    
    
(in millions)
 
Gross profit
   $ 454.9     $ 461.6     $ (6.7
Percent of total revenues
     60.2     59.1     1.1  
Gross profit as a percent of revenue increased by 1.1 points, primarily due to product mix in Semiconductor Test.
Selling and Administrative
Selling and administrative expenses were as follows:
 
    
For the Three Months

Ended
       
    
April 3,
2022
   
April 4,
2021
   
Dollar
Change
 
                    
    
(in millions)
 
Selling and administrative
   $ 140.2     $ 129.8     $ 10.4  
Percent of total revenues
     18.6     16.6  
The increase of $10.4 million in selling and administrative expenses was primarily due to higher spending in Industrial Automation and Semiconductor Test, partially offset by lower variable compensation.
 
30

Table of Contents
Engineering and Development
Engineering and development expenses were as follows:
 
    
For the Three Months

Ended
       
    
April 3,
2022
   
April 4,
2021
   
Dollar
Change
 
                    
    
(in millions)
 
Engineering and development
   $ 108.1     $ 100.4     $ 7.7  
Percent of total revenues
     14.3     12.8  
The increase of $7.7 million in engineering and development expenses was due to higher spending across all segments, partially offset by lower variable compensation.
Restructuring and Other
During the three months ended April 3, 2022, we recorded a charge of $14.7 million related to the arbitration claim filed against Teradyne and AutoGuide related to an earn-out dispute, which was settled on March 25, 2022 for $26.7 million. Previously, in the three months ended December 31, 2021, we recorded a charge of $12.0 million related to this earn-out dispute.
During the three months ended April 4, 2021, we recorded a gain of $7.2 million for the decrease in the fair value of the AutoGuide contingent consideration liability.
Interest and Other
 
    
For the Three Months

Ended
        
    
April 3,
2022
    
April 4,
2021
    
Dollar
Change
 
                      
    
(in millions)
 
Interest income
   $ (0.7    $ (0.8    $ 0.1  
Interest expense
     1.0        6.0        (5.0
Other (income) expense, net
     5.2        3.8        1.4  
Interest expense decreased by $5.0 million primarily due to the January 1, 2022 adoption of ASU
2020-06
which eliminated the amortization of the debt discount which was $3.6 million in the three months ended April 4, 2021. Other (income) expense, net increased by $1.4 million primarily due to changes in unrealized gains/losses on equity securities, from a $1.4 million gain in 2021 to a $2.2 million loss in 2022, partially offset by lower losses on convertible debt early conversions.
Income (Loss) Before Income Taxes
 
    
For the Three Months

Ended
        
    
April 3,
2022
    
April 4,
2021
    
Dollar
Change
 
                      
    
(in millions)
 
Semiconductor Test
   $ 149.7      $ 176.4      $ (26.7
System Test
     41.3        51.1        (9.8
Wireless Test
     18.6        9.6        9.0  
Industrial Automation
     (5.1      (13.0      7.9  
Corporate and Eliminations (1)
     (24.2      (0.1      (24.1
  
 
 
    
 
 
    
 
 
 
   $ 180.4      $ 224.0      $ (43.6
  
 
 
    
 
 
    
 
 
 
 
(1)
Included in Corporate and Eliminations are legal fees, contingent consideration adjustments, interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, acquisition related charges and compensation and for the three months ended April 4, 2021, loss on convertible debt conversions.
 
31

Table of Contents
The decrease in income before income taxes in Semiconductor Test was driven primarily by lower revenues in compute processor and industrial applications and lower memory test sales of flash memory testers. The decrease in income before income taxes in System Test was primarily due to lower sales in Storage Test of system level and hard disk drive testers, partially offset by greater sales in Defense/Aerospace and Production Board Test. The elevated income before taxes in Industrial Automation was driven primarily by higher demand for collaborative robotic arms and MiR’s autonomous mobile robots. The rise in income before taxes in Wireless Test was driven primarily by an increase in connectivity test products and higher demand in ultra-wide band wireless test. The loss before income taxes in Corporate and Eliminations was primarily due to legal settlement charges related to litigation for the
earn-out
dispute in connection with the AutoGuide acquisition.
Income Taxes
The effective tax rate for the three months ended April 3, 2022 and April 4, 2021 was 10.2% and 8.3%, respectively. The increase in the effective tax rate from the three months ended April 4, 2021 to the three months ended April 3, 2022 was primarily attributable to a projected shift in the geographic distribution of income, which increases the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions, and an increase in
non-deductible
officers’ compensation. These increases in expense were partially offset by an increase in benefit from equity compensation.
Contractual Obligations
There have been no changes outside of the ordinary course of business to our contractual obligations as disclosed in our Annual Report on Form
10-K
for the year ended December 31, 2021.
Liquidity and Capital Resources
Our cash, cash equivalents, and marketable securities balances decreased by $297.5 million in the three months ended April 3, 2022 to $1,202.7 million.
Operating activities during the three months ended April 3, 2022 provided cash of $7.5 million. Changes in operating assets and liabilities used cash of $210.2 million. This was due to an $83.6 million increase in operating assets and a $126.6 million decrease in operating liabilities.
The increase in operating assets was due to a $74.3 million increase in prepayments and other assets due to prepayments to our contract manufacturers, a $9.5 million increase in inventories, partially offset by a $0.2 million decrease in accounts receivable.
The decrease in operating liabilities was due to a $114.0 million decrease in accrued employee compensation, a $13.8 million decrease in other accrued liabilities, a $7.6 million decrease in income taxes, and $1.3 million of retirement plan contributions, partially offset by a $6.7 million increase in deferred revenue and customer advance payments, and a $3.4 million increase in accounts payable.
Investing activities during the three months ended April 3, 2022 used cash of $82.7 million due to $166.0 million used for purchases of marketable securities, and $44.0 million used for purchases of property, plant and equipment, partially offset by $96.7 million and $30.6 million in proceeds from maturities and sales of marketable securities, respectively.
Financing activities during the three months ended April 3, 2022 used cash of $254.6 million due to $201.5 million used for the repurchase of 1.8 million shares of common stock at an average price of $115.12 per share, $31.0 million used for payment related to net settlements of employee stock compensation awards, $20.7 million used for payments of convertible debt principal, $17.9 million used for dividend payments, partially offset by $16.5 million from the issuance of common stock under employee stock purchase and stock option plans.
Operating activities during the three months ended April 4, 2021 provided cash of $38.1 million. Changes in operating assets and liabilities used cash of $209.1 million. This was due to a $209.5 million increase in operating assets and a $0.4 million increase in operating liabilities.
The increase in operating assets was due to an $87.5 million greater accounts receivable due to improved sales, an $86.1 million increase in prepayments and other assets due to prepayments to our contract manufacturers as a result of higher forecasted revenues, and a $35.9 million rise in inventories.
 
32

Table of Contents
The change in operating liabilities was due to a $44.5 million rise in accounts payable, a $26.4 million increase in other accrued liabilities, an $8.0 million increase in deferred revenue and customer advance payments, and a $4.9 million increase in income taxes, partially offset by an $81.5 million decrease in accrued employee compensation and $1.9 million of retirement plan contributions.
Investing activities during the three months ended April 4, 2021 provided cash of $4.7 million due to $194.2 million and $61.3 million in proceeds from maturities and sales of marketable securities, respectively, partially offset by $211.6 million used for purchases of marketable securities, and $39.3 million used for purchases of property, plant and equipment.
Financing activities during the three months ended April 4, 2021 used cash of $126.7 million, due to $51.3 million used for payments of convertible debt principal, $45.2 million used for the repurchase of 0.4 million shares of common stock at an average price of $120.73 per share, $30.7 million used for payments related to net settlements of employee stock compensation awards, and $16.7 million used for dividend payments, partially offset by $17.1 million from the issuance of common stock under employee stock purchase and stock option plans.
In January 2022, Teradyne’s Board of Directors declared a 10% increase in the quarterly cash dividend to $0.11 per share. Dividend payments for the three months ended April 3, 2022 were $17.9 million. In January 2021, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the three months ended April 4, 2021 were $16.7 million.
In January 2021, our Board of Directors approved a new repurchase program for up to $2.0 billion of common stock. Unless terminated by resolution of our Board of Directors, the repurchase program will expire when we have repurchased all shares authorized for repurchase under the share repurchase program. We intend to repurchase a minimum of $750.0 million in 2022.
During the three months ended April 3, 2022, we repurchased 1.8 million shares of common stock for $201.5 million at an average price of $115.12 per share. During the three months ended April 4, 2021, we repurchased 0.4 million shares of common stock for $45.2 million at an average price of $120.73 per share.
While we declared a quarterly cash dividend and authorized a share repurchase program, we may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of our Board of Directors, which will consider, among other things, our earnings, capital requirements and financial condition.
On May 1, 2020, we entered into a credit agreement providing a three-year, senior secured revolving credit facility of $400 million. On December 10, 2021, the credit agreement was amended to extend the senior secured revolving credit facility to December 10, 2026. As of May 6, 2022, we have not borrowed any funds under the credit facility.
We believe our cash, cash equivalents and marketable securities balance will be sufficient to pay our quarterly dividend and meet our working capital and expenditure needs for at least the next twelve months. Inflation has not had a significant long-term impact on earnings. At this time, the
COVID-19
pandemic has not had an impact on our liquidity, but there is no assurance that continued impacts resulting from the pandemic will not have an adverse effect in the future.
Equity Compensation Plans
As discussed in Note Q: “Stock-Based Compensation” in our 2021 Annual Report on Form
10-K,
we have a 1996 Employee Stock Purchase Plan and a 2006 Equity and Cash Compensation Incentive Plan (the “2006 Equity Plan”).
The purpose of the 1996 Employee Stock Purchase Plan is to encourage stock ownership by all eligible employees of Teradyne. The purpose of the 2006 Equity Plan is to provide equity ownership and compensation opportunities in Teradyne to our employees, officers, directors, consultants and/or advisors. Both plans were approved by our shareholders.
Recently Issued Accounting Pronouncements
For the three months ended April 3, 2022, there were no recently issued accounting pronouncements that had, or are expected to have, a material impact to our consolidated financial statements.
 
Item 3:
Quantitative and Qualitative Disclosures about Market Risks
For “Quantitative and Qualitative Disclosures about Market Risk” affecting Teradyne, see Part 2 Item 7A, “Quantitative and Qualitative Disclosures about Market Risks,” in our Annual Report on Form
10-K
filed with the SEC on February 23, 2022. There were no material changes in our exposure to market risk from those set forth in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2021.
 
 
33

Table of Contents
In addition to market risks described in our Annual Report on Form
10-K,
we have an equity price risk related to the fair value of our convertible senior unsecured notes issued in December 2016. In December 2016, Teradyne issued $460 million aggregate principal amount of 1.25% convertible senior unsecured notes (the “Notes”) due December 15, 2023. As of April 3, 2022, $96.3 million of principal remained outstanding and the Notes had a fair value of $323.7 million. The table below provides a sensitivity analysis of hypothetical 10% changes of Teradyne’s stock price as of the end of the first quarter of 2022 and the estimated impact on the fair value of the Notes. The selected scenarios are not predictions of future events, but rather are intended to illustrate the effect such event may have on the fair value of the Notes. The fair value of the Notes is subject to equity price risk due to the convertible feature. The fair value of the Notes will generally increase as Teradyne’s common stock price increases and will generally decrease as the common stock price declines in value. The change in stock price affects the fair value of the Notes, but does not impact Teradyne’s financial position, cash flows or results of operations due to the fixed nature of the debt obligation. Additionally, we carry the Notes at face value less unamortized discount on our balance sheet, and we present the fair value for required disclosure purposes only. In connection with the offering of the Notes we also sold warrants to the option counterparties. These transactions have been accounted for as an adjustment to our shareholders’ equity. The convertible note hedge transactions are expected to reduce the potential equity dilution upon conversion of the Notes. The warrants along with any shares issuable upon conversion of the Notes will have a dilutive effect on our earnings per share to the extent that the average market price of our common stock for a given reporting period exceeds the applicable strike price or conversion price of the warrants or Notes, respectively.
 
Hypothetical Change in Teradyne Stock Price
  
Fair Value
    
Estimated change
in fair value
    
Hypothetical percentage
increase (decrease)

in fair value
 
                      
10% Increase
   $ 359,092      $ 35,422        10.9
No Change
     323,670        —          —    
10% Decrease
     288,248        (35,422      (10.9
 
Item 4:
Controls and Procedures
As of the end of the period covered by this report, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule
13a-15(b)
or Rule
15d-15(f)
promulgated under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that material information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, including ensuring that such material information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
There have been no changes in our internal control over financial reporting (as defined in Rules
13a-15(f)
and
15d-15(f)
under the Exchange Act) during the three months ended April 3, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
 
Item 1:
Legal Proceedings
We are subject to various legal proceedings and claims which have arisen in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. Teradyne believes that it has meritorious defenses against all pending claims and intends to vigorously contest them. While it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, Teradyne believes the potential losses associated with all of these actions are unlikely to have a material adverse effect on its business, financial position or results of operations.
On March 8, 2021, Industrial Automation LLC submitted a demand for arbitration against Teradyne and AutoGuide in Wilmington, Delaware alleging that Teradyne and AutoGuide breached certain provisions of the Membership Interests Purchase Agreement (the “Purchase Agreement”), dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide. The arbitration demand sought full acceleration of the maximum
earn-out
amount payable under the Purchase Agreement, or $106.9 million, for the alleged breach of the
earn-out
provisions of the Purchase Agreement. On March 25, 2022, the arbitration claim was settled for $26.7 million. As a result, Teradyne has no remaining
earn-out
obligations.
 
34

Table of Contents
Item 1A:
Risk Factors
In addition to other information set forth in this Form
10-Q,
including the risk discussed below, you should carefully consider the factors discussed in Part I, “Item 1A: Risk Factors” in our Annual Report on Form
10-K
for the year ended December 31, 2021, which could materially affect our business, financial condition or future results. The risk factors described in our Annual Report on Form
10-K
remain applicable to our business and many of these risks could be further increased due to the
COVID-19
pandemic.
The risks described in our Annual Report on Form
10-K
are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
The global supply shortage of electrical components has impacted our ability to meet customer demand.
There is currently a global supply shortage of electrical components, including semiconductor chips. As a result, we have experienced increases in our lead times and costs for certain components for certain products and delays in the delivery of some orders placed by our customers. If we are unable to secure manufacturing capacities from our current suppliers and contract manufacturers, our ability to deliver our products to our customers may be negatively impacted for the remainder of 2022 and into 2023. Also, our suppliers and contract manufacturers may increase their prices, which would result in an increase in our manufacturing costs, which we may not be fully able to pass to our customers, which could have a negative impact on our results of operations and financial condition.
 
Item 2:
Unregistered Sales of Equity Securities and Use of Proceeds
In January 2021, Teradyne’s Board of Directors approved a new repurchase program for up to $2.0 billion of common stock. During the three months ended April 3, 2022, we repurchased 1.8 million shares of common stock for $201.5 million at an average price of $115.12 per share. During the three months ended April 4, 2021, we repurchased 0.4 million shares of common stock for $45.2 million at an average price of $120.73 per share. The cumulative repurchases under the $2.0 billion common stock repurchase program as of April 3, 2022 were 6.5 million shares of common stock for $801.5 million at an average price per share of $122.89.
The following table includes information with respect to repurchases we made of our common stock during the three months ended April 3, 2022 (in thousands except per share price):
 
Period
  
(a) Total

Number of

Shares

(or Units)

Purchased
   
(b) Average

Price Paid per

Share (or Unit)
   
(c) Total Number of

Shares (or Units)

Purchased as Part of

Publicly Announced

Plans or Programs
    
(d) Maximum Number

(or Approximate Dollar

Value) of Shares (or

Units) that may Yet Be

Purchased Under the

Plans or Programs
 
                           
January 1, 2022 - January 30, 2022
     194     $ 140.33       —        $ 1,400,000  
January 31, 2022 - February 27, 2022
     793     $ 115.59       767      $ 1,311,601  
February 28, 2022 - April 3, 2022
     986     $ 114.96       984      $ 1,198,536  
  
 
 
   
 
 
   
 
 
    
     1,973 (1)    $ 117.71 (1)      1,751     
  
 
 
   
 
 
   
 
 
    
 
(1)
Includes approximately two hundred twenty-four thousand shares at an average price of $137.98 withheld from employees for the payment of taxes.
We satisfy U.S. federal and state minimum withholding tax obligations due upon the vesting and the conversion of restricted stock units into shares of our common stock, by automatically withholding from the shares being issued, a number of shares with an aggregate fair market value on the date of such vesting and conversion that would satisfy the minimum withholding amount due.
 
Item 4:
Mine Safety Disclosures
Not Applicable
 
35

Table of Contents
Item 6:
Exhibits
 
Exhibit
Number
  
Description
31.1    Certification of Principal Executive Officer, pursuant to Rule 13a-14(a) of Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
31.2    Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) of Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
32.1    Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)
32.2    Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)
101.INS    Inline XBRL Instance Document
101.SCH    Inline XBRL Taxonomy Extension Schema Document
101.CAL    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB    Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File (formatted as Inline XBRL, and contained in Exhibit 101)
 
36

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
TERADYNE, INC.
Registrant
/s/ S
ANJAY
M
EHTA
Sanjay Mehta
Vice President,
Chief Financial Officer and Treasurer
(Duly Authorized Officer
and Principal Financial Officer)
May 6, 2022
 
 
37